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Abstract 
Many hospitalizations have been considered preventable if health practitioners 
through management programs and interventions can address early disease 
symptoms and identify exactly potential risk factors related to patient or healthcare 
system level causing these hospitalizations. However, it seems to be lack of a 
reliable method to indicate the risk factors and predict patients at risk of 
hospitalizations in practice.  
Accordingly, the goal of this thesis was to provide an in-depth application of 
Random Forests (RF), a machine learning technique, in order to specify and 
examine important factors for predicting hospitalizations and/or rehospitalizations 
of patients with COPD. Using claims data from a single, large, Midwestern, self-
insured employer group, the first part of this dissertation built and validated several 
RF models to get the final reliable models for identifying the contributing predictors. 
The final RF model for hospitalization prediction presented high accuracy (89 %), 
high sensitivity (83 %), high specificity (0.93), high value of c-statistic (0.88), and 
good agreement (Kappa = 0.77). The final RF model for rehospitalization 
prediction presented high accuracy (89 %), high sensitivity (100 %), high specificity 
(0.83), high value of c-statistic (0.92), and good agreement (Kappa = 0.79). In the 
second part, the core of our contributions focused on identifying variable 
importance for hospitalization and/or rehospitalization by using the Mean 
Decrease of Impurity variable importance measure (i.e., Mean Decrease of Gini).  
In consequence of this work, our analyses demonstrated that important variables 
for hospitalization prediction included comorbidity index, outpatient visit, care 
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management, prescription of COPD drugs, prescription of cardiovascular drugs, 
and number of prescriptions. For rehospitalization prediction, important variables 
were comorbidity index, post-discharge prescription of COPD drugs, pre-discharge 
care management, length of stay in hospital, gender, pre-discharge number of 
prescriptions, post-discharge prescription of cardiovascular drugs, and emergency 
room visit. Finally, the last part of this dissertation indicated a possibility of applying 
our models to practice by ranking patients at different levels of risks to 
hospitalization and/or rehospitalization. In the analytic sample for the 
hospitalization prediction, the final model predicted 51.0 % at low risk level (P 
Hospitalization < 50), 23.1 % at the medium risk level (50 % ≤ P Hospitalization < 80 %), and 
25.9 % of patients at high risk level (i.e., P Hospitalization ≥ 80 %). In the analytic sample 
for the rehospitalization prediction, the final model found 53.6 % at low risk level 
(P Rehospitalization < 50), 16.9 % at the medium risk level (50 % ≤ P Rehospitalization < 80 
%), and 29.5 % of patients at high risk level (P Rehospitalization ≥ 80 %). 
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Chapter 1. INTRODUCTION 
This chapter divides into three parts:  background, objectives and specific aims, 
and key terms and definitions. The first part summarizes current issues in health 
care that triggered research questions for this study. The second part describes 
the objectives and aims addressing the posed research questions. Finally, it 
presents a table of key terms and definitions used in this dissertation. 
1.1. Background 
Historically, in the United States, hospitalizations have accounted for 
approximately half of all healthcare expenditures. Importantly, while inpatient 
services account for a small amount of total healthcare utilization, these services 
contribute the largest share of total healthcare expenses in the United States 
(Kashihara & Carper, 2012). For instance, while the total health care expenditure 
was $ 2.593 trillion, the total cost for all hospital care was $ 814 billion in 2010, 
approximately 31.4 % of the total health care expenditure (Centers for Medicare 
and Medicaid Services, 2010).   
Hospitalization rates depend on a variety of factors.  For example, patient health 
status and health services access are important factors. While health status often 
influences risk of hospitalization in a one-way direction, health service access can 
influence risk of hospitalization in several directions (Kangovi & Grande, 2011). 
Worsening health conditions, for instance, increases the likelihood of 
hospitalization. However, a low level of health services access can lead to both 
high and low risk of hospitalization. Decreasing access to health services (e.g., 
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lack of transportation) can reduce patients’ adherence with treatment plans that 
will put patients at high risk of rehospitalization. At the same time, decreasing the 
access (e.g., emergency departments strictly justify patients for hospitalization to 
avoid readmission penalties) can reduce rehospitalization.  
A large portion of hospitalizations is considered potentially avoidable. The 
hospitalizations include both initial hospitalizations and rehospitalizations — i.e., a 
readmission to a hospital within a specific time interval, following a prior admission 
and discharge. Recently, health policy makers have focused attention on 
rehospitalizations. The Centers for Medicare and Medicaid (CMS) launched the 
Hospital Readmission Reduction Program (HRRP) to improve healthcare cost 
saving at hospitals by reducing avoidable rehospitalizations (American Hospital 
Association, 2014). The HRRP, authorized by the U.S Patient Protection and 
Affordable Care Act, required a reimbursement penalty charged to hospitals with 
an excessive rehospitalization rate.  Hospitals with high readmission rates for 
certain disease conditions including acute myocardial infarction, heart failure, and 
pneumonia have been penalized one percent of their Medicare budget since Oct. 
1, 2012. 
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             Figure 1. Percent of rehospitalizations penalty by US states FY 2015 
                  Source: (The SafeCare Group, 2014) 
As a result, over 2,000 hospitals across US paid approximately $280 million in 
Medicare funds in Fiscal Year (FY) 2013 (J. Rau, 2012). The penalty grew to 2 
percent in FY 2014 and inflated to 3 percent in FY 2015. CMS charged $428 million 
in penalties against 2,637 hospitals in FY 2015, with Kentucky having the highest 
percentage average penalty (see Figure 1). Minnesota was in a group of states 
with low penalty charges (from 0.25% to 0.49%) (see Figure 1), but the percent of 
penalized hospitals was high, from 48 percent to 66 percent (see Figure 2).  
 
    Figure 2. Percent of penalized hospitals by the U.S states  
                                     Source: (Kaiser Health News, 2013) 
The range of a time interval (i.e., time from discharge to readmitted date) for a 
readmission can affect the rehospitalization rate. While the HRRP of CMS uses a 
30-day period, there has been unclear validation for reliability and accuracy of the 
period yet. Various periods, from seven days to one year, have been examined 
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and the result showed percent of hospitalizations would be largely varied, if the 
period was changed (Stone & Hoffman, 2010). In 2005, for example, a report 
indicated that 17.6% of all-cause hospitalizations followed by readmissions in a 
30-day period after discharge, 11.3% within 15 days, and 6.2% within 7 days 
(MedPAC, 2007).  
The rehospitalization rate also depends on specific disease conditions. In a 
recently published study, five disease conditions were accounted for 
approximately 80 percent of avoidable hospitalizations: congestive heart failure 
(21%), chronic obstructive pulmonary disease (COPD)/asthma (20%), urinary tract 
infections (15%), pneumonia (13%), and dehydration (11%) (Segal, Rollins, 
Hodges, & Roozeboom, 2014). Early presentation of patient to the physician for 
these conditions allows early intervention that would potentially reduce disease 
progression and the risks of hospitalizations. Thus, it is possible to manage these 
five conditions in an outpatient setting with timely and effective treatment to avoid 
hospitalizations, thereby preventing excessive costs for inpatient services.  
Hospitalization and rehospitalization for patient with COPD are the foci of this 
study. Patients  with COPD normally have a poor understanding of their disease 
and symptoms, thus they usually experience exacerbations that are a major cause 
of hospitalizations (Maselli & Anzueto, 2012). Because of the preventable nature 
of the hospitalizations related to these COPD exacerbations, the HRRP included 
COPD as a part of the program in October 2014 (Feemster & Au, 2014).  
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At the state level, Kentucky had the highest COPD hospitalization rates, while Utah 
and California had the lowest (Holt, Zhang, Presley-cantrell, & Croft, 2011). Ten 
states, geographically located together in the eastern Midwest (Indiana and Ohio) 
and the southern area of the US (Kentucky, West Virginia, Tennessee, Mississippi, 
Alabama, Arkansas, Louisiana and Oklahoma) have the highest COPD 
hospitalization rates (see Figure 3).  
 
     Figure 3. COPD hospitalization rate by state (1995 – 2006)  
                    Source: (Holt et al., 2011) 
These findings related to COPD hospitalization rates are geographically consistent 
with smoking rates across the US. States with high smoking rates are associated 
with high hospitalization rates among COPD patients (see Figure 4). 
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           Figure 4. Smoking rates across US. States 
      Source: (Centers for Disease Control and Prevention, 2015) 
To deal with the increasing COPD hospitalization rates, various interventions and 
management programs have been proposed over the past ten years. The 
proposals have aimed at reducing hospitalizations, avoiding penalty charges, and 
improving the quality of care. The interventions and programs have included 
transitional care interventions, patient education, follow-up telephone calls, and 
pre-& post-discharge home visits. Such programs will facilitate their aims, if risk 
predictive models are developed to clarify patients at high risk of hospitalizations 
and forecast the likelihood of future hospitalizations. Ideally, the models will can 
provide clinically relevant stratification of rehospitalization and other information 
early enough during hospital stays to activate a transitional care intervention or 
pre-& post-discharge planning. 
In today’s era of Big Data, the use of predictive modeling has become a promising 
tool in many areas such as computer science, marketing, and business. 
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Expectedly, predictive modeling will play an important role in forecasting the 
likelihood of future events in health care organizations over the next decade. 
Findings from literature, however, indicate two primary gaps in the development 
and use of predictive modeling for hospitalizations. First, there are only a few risk 
predictive models for both hospitalization and rehospitalization and most have poor 
predictive ability (Kansagara, Kagen, Theobald, & Freeman, 2011). Secondly, 
although prior research has described the relationship between hospitalization (or 
rehospitalization) and a set of predictors using regression modeling, it often 
remains unclear to policy makers and healthcare practitioners which predictor or 
group of predictors is the most influential in hospitalization (or rehospitalization) 
prediction.  
Overall, these gaps could be due to several reasons. First, since there is no 
agreement on a unified definition of avoidable hospitalization, the use of different 
definitions results in a broad range of rehospitalization rates and divergent 
implemented strategies to prevent such hospitalizations among hospitals. Second, 
the period used to define the rehospitalization event should be different in nature 
for each type of illness; CMS established only the 30-day period, thereby 
generating inaccurate prediction. Third, both healthcare system efficiencies and 
quality of care delivery can influence the likelihood of initial hospitalization and 
subsequent hospitalizations. Predictive modeling, however, is impossible to reflect 
all of aspects of health care that affects reliability and validity of a model. Finally, 
the risk factors for hospitalization (or rehospitalization) can come from a variety of 
levels of healthcare data such as patient-level data (gender and age of patient), 
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provider-level data (years of experience), or hospital-level data (bed supply), 
thereby making their associations complicated within the data sets used for the 
modeling exercises. More importantly, there is a lack of appropriate statistical 
approach to deal with the complication in practice.  
Healthcare claims data is usually used in predictive modeling. Non-linear 
relationships and high-level interactions between and among variables commonly 
occur in healthcare data sets.  Logarithmic transformation or polynomial regression 
are options to deal with non-linear relationships. Log transformation is to obtain an 
approximate normality and homogeneity of variance. Polynomial regression is 
applied for fitting a curvilinear relationship. Determining the appropriate 
transformation of healthcare utilization, however, is often difficult due to the large 
number of independent variables and high interactions between and among the 
variables and unknown form of polynomial regression.  
In practice of health outcomes research, there is a need for an approach to 
predictive modeling that possibly limit statistical assumptions, handle well the 
effect of attribute interactions to incorporate into the model, and allow classifying 
patients at risk of hospitalizations and/or rehospitalizations, identifying the most 
influential risk factors, and accurately predicting future events. Random Forests 
(RF) statistical model, a type of machine-learning techniques, would fulfill the gaps 
regarding to predictive modelling in current study. RF is a classification algorithm 
that aggregates tree-structured classifiers and an effective tool in prediction. RF 
was originally proposed by Leo Breiman in the 2000’s for building predictive 
models (L. Breiman, 1999). Since then, RF has emerged as a reliable method that 
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can produce highly accurate predictions and handle large number of input 
variables without over fitting the model. Recently, RF has been successfully 
applied in a number of areas such as genetics, pharmacology, and cellular & 
molecular biology (Izmirlian, 2004; Ward, Pajevic, Dreyfuss, & Malley, 2006; Wu 
et al., 2009). In a 2007 study, the RF technique demonstrated the best 
performance of prediction as authors compared RF to other models including 
artificial neural network, support vector machine, k-nearest neighbor, linear 
discriminant analysis, shrunken centroid, logistic regression, and boosting (Moon 
et al., 2007). In our study, we will adapt the RF approach to address the gaps 
regarding statistical methods and knowledge in the previous studies used to 
identify risk factors for hospitalization and rehospitalization. 
1.2. Objective and Specific Aims 
To manage both cost saving and quality improvement of chronic disease care, 
many chronic care management programs consider patient & disease 
management as crucial components of the programs. Patient & disease 
management from admission to discharge is an interaction between patient and 
healthcare team that includes examination, diagnosis, or intervention. Although 
there are many new concepts, techniques, or tests involved in patient & disease 
management to improve diagnosis and treat symptoms for chronic conditions, a 
circle of hospitalizations (i.e., hospitalization, discharge, and rehospitalization) 
seems to be unstoppable over time for patients with chronic diseases. Since this 
circle is not only costly but also causes morbidity or mortality for patients, it turns 
out to be a big challenge for care management programs.  For COPD, the chronic 
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condition of interest for this dissertation, the broad range of severity can begin from 
mild impairment to serious exacerbations involving many uncertain risk aspects 
that lead patient to hospitalizations and/or rehospitalizations. Thus, the patient care 
management for COPD is costly, lengthy, and complicated. To address 
complications directly relevant to COPD patient and disease management, three 
questions emerge for policy makers and healthcare practitioners:  
1. Are hospitalizations for patients with COPD preventable? 
2. What are the main factors contributing to a hospitalization and/or 
rehospitalization for COPD patients?  
3. Is there a statistical approach that could reliably identify the greatest 
contributing factors in predicting a hospitalization and/or a rehospitalization 
for COPD? 
In this study, I am proposing the following aims and hypotheses to address these 
questions: 
Aim1: to specify and examine important factors for predicting hospitalizations of 
COPD patients.  
Hypothesis:  A combination of two or more variables associated with patient 
demographics, health utilization, and health status predicts risk of all-cause 
hospitalizations for COPD patients.   
Aim2: to verify and examine important predictors which predict subsequent 
hospitalizations of COPD patients  
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Hypothesis:  A combination of two or more variables related to patient 
demographics, health utilization, and health status predicts risk of all-cause re-
hospitalizations for COPD patients. 
1.3. Key Terms and Definitions 
This part shows all key terms used in this study and their definitions (see Table 1) 
Terms Definition 
Random Forest A type of machine learning techniques operated by assembling 
multiple decision tree models and averaging the mode of classes 
(classification) or mean prediction of individual trees (regression) 
COPD Chronic obstructive pulmonary disease 
Hospitalization  Initial admission to hospital for all-cause diagnosis  
Rehospitalization  
 
Readmission to hospital for all-cause diagnosis within a specific 
time interval, following a prior admission and discharge 
ICD-9 CM International classification of Disease (ICD), ninth revision, clinical 
modification (CM). ICD-9 CM is modified from ICD-9 that is ICD 
Ninth revision of World Health Organization (WHO). ICD-9 CM is 
the official system assigned codes to diagnoses and procedures 
associated with hospital utilizations 
CMS Centers for Medicare & Medicaid Service 
The Hospital 
Readmission 
Reduction 
Program 
Section 3025 of the Affordable Care Act added section 1886(q) to 
the Social Security Act establishing the Hospital Readmissions 
Reduction Program, which requires CMS to reduce payments to 
IPPS hospitals with excess readmissions, effective for discharges 
12 
 
beginning on October 1, 2012. The regulations that implement this 
provision are in subpart I of 42 CFR part 412 (§412.150 through 
§412.154) 
Early goal 
directed therapy 
A therapy involves intensive monitoring and management of a 
specific disease condition in patients who have high risk of 
morbidity and mortality 
Care 
management  
The goal of care management is to achieve an optimal level of 
wellness and improve care for patient while providing cost-effective 
services 
Patient 
management  
A description of the interaction, from admission to discharge, 
between the patient and the health care team includes 
communication, examination, diagnosis, and intervention 
Disease 
management 
Disease management aims at reducing health care costs and 
improving quality of life for patients with chronic conditions by 
preventing or minimizing the effects of the disease through 
integrated care  
               
Table 1. Definition of used terms 
1.4. Significance and Innovation of the Study 
Significantly, this study filled a gap in literature related to identifying risk factors 
associated with hospitalizations for COPD population. CMS recently identified 
early readmissions of patients with COPD as a quality metric for hospital 
performance. Given this lately introduced CMS requirement, this study is extremely 
well timed. The result from this study will directly address the issue of excessive 
hospitalizations that are occurring in COPD population. The study will contribute 
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effectiveness of many interventions or programs to improve quality of care, quality 
of life, and patient management of persons with COPD.  
This study will be a key strategy in meeting the policy implications of the CMS 
hospital performance policy. Ultimately, study findings will contribute to the 
appropriate utilization of hospital-based resources leading to more cost-
effectiveness of care. Importantly, the successful model of study will be able to 
contribute to decision making in assignment of patients to treatments based on risk 
factors and disease characteristics.  
This study will facilitate early intervention and goal-directed therapy by precisely 
identifying risk factors and reliably predicting patients at high risk of hospitalization 
(or rehospitalization).  Consequently, patient care will be more cost-effective 
utilization of limited medical resource and improve quality of life for patients. With 
a robust method, this study will bring into practice a valid risk assessment tool that 
can be used for hospital comparison, public reporting, and reimbursement 
determinations. 
While the RF has been applied widely and successfully in electrical engineering 
and computer science (e.g., Kinect for XBox 360), few healthcare researches have 
applied this analytic technique. The innovative contribution of this work is the 
application of the RF to a conceptual problem in the healthcare field. In addition, 
the results of this study will contribute to develop a novel tool that can be practically 
used by clinics and/or hospitals to reduce hospital visits related to preventable 
hospital admissions or readmissions. Obviously, the predictive modeling is a new 
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and promising area that will be very necessary for development of healthcare 
industry.  Success of this study is a valuable contribution to both practical and 
theoretical application in this area. 
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Chapter 2. LITERATURE REVIEW 
This chapter describes quality measures and modeling approaches that have been 
developed to identify potentially preventable hospitalizations (PPH). It intends to 
provide an understanding of PPH definition and measurement, PPH-related risk 
factors, and predictive modeling approaches for the identification of PPHs for 
patients with specific disease conditions. The disease condition of concern in this 
study is the population of patients with COPD. To address these purposes, this 
chapter presents a review of these aspects:  
 Preventability of hospitalization and/or rehospitalization 
 Definition and rationale focusing on PPH 
 PPHs associated with quality of care and hospital performance 
 Measure for PPH 
 Risk factors  
 Time frame 
 Penalty for excessive PPHs related to COPD 
 Current modeling approaches  
 Random forest approach-a technique of data mining 
Even though there is no ultimate database that will identify all literature related to 
the research questions, this current study used PubMed, Ovid MEDLINE, and 
Google Scholar for searching articles. While Google Scholar is considered a 
general reference index, one of the most popular tools when looking for relevant 
articles, PubMed and Ovid MEDLINE are usually used to search medical-subject 
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related articles. In addition, we scanned the reference lists from retrieved articles 
to identify additional studies that could be missed during the initial search.  
The criteria for searching included disease condition with an emphasis on chronic 
disease and COPD, the topics related to risk predictions and risk events for 
hospitalization and rehospitalization. Searching key words covered in various 
combinations included Chronic Obstructive Pulmonary Disease (COPD), 
hospitalization, rehospitalization, admission, readmission, predictive model, 
random forest model, predictor, and risk factor. 
We excluded studies that focused on psychiatric and pediatric populations 
because the risk factors contributing to hospitalization and/or rehospitalization are 
just specifically reflected for these populations, not generalized for others. 
Abstracts were evaluated if they are relevant to the study aims. Full articles 
regarding predictive models, the risk factors of hospitalization and/or 
rehospitalization were identified for further review and evaluation. The selected 
articles were published within the period 1980 to 2015 in English.  
2.1. Preventability of hospitalization and/or rehospitalization 
2.1.1. Definition and rationale for focusing on PPH 
In literature, the term “Potentially preventable hospitalization” is commonly used to 
refer to both initial hospital admission and readmission for certain acute illnesses 
(e.g., asthma attack and dehydration ) or worsening chronic conditions (e.g., 
COPD and diabetes) that can be preventable if these conditions are successfully 
managed by healthcare practitioners in outpatient settings (Moy, Chang, & Barett, 
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2013). A preventable hospitalization could be due to incomplete treatment or poor 
care of underlying problems (e.g., patient weakness and progression of chronic 
disease). It reflects poor coordination of healthcare services such as inadequate 
access to care, lack of follow-up care, or incomplete discharge planning. Several 
randomized prospective trials estiamted that 12% to 75% of all readmissions were 
preventable by patient education, pre-discharge assessment, and homecare 
(Benbassat & Taragin, 2000).  
There is a need for healthcare providers to manage patients consistently in multiple 
periods included both pre- and post-discharge to reduce the cost of PPHs as much 
as possible. Clinical practice indicates that many factors can affect the likelihood 
of hospitalization events during many months before and following a 
hospitalization. For example, Coleman and Berenson (2004) stated that patients 
were usually expected to accept a self-management role in recovery with little 
support and preparation, while they tended to depend on family members at home 
or their professional caregivers in hospital to make decision regarding 
hospitalization or discharge (Coleman & Berenson, 2004). Another example is the 
long-term adherence to medication regimens that can help to decrease the further 
hospitalization events. Lappe’ et al., (2004) indicated that if medications were 
prescribed at hospital discharge, the chances of long-term adherence to 
medication regimens were significantly higher (Lappé et al., 2004). Experts also 
noted that a hospital-based discharge program could be more easily implemented, 
more effectively managed and measured, and more cost-effective than other 
potential outpatient intervention strategies (Lappé et al., 2004).  
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2.1.2. PPHs associated with quality of care and hospital performance 
In the U.S., early hospitalization related studies were mostly driven by increasing 
awareness of the high cost of healthcare utilization and rehospitalization that 
consumed a disproportionate share of expenditures for inpatient hospital care 
(Anderson & Steinberg, 1984). Based on data from the mid-1970s, Anderson and 
Steinberg (1984) published an in uential study showing that 23% of Medicare 
beneficiaries’ hospitalizations were followed by rehospitalization within 60 days 
and these rehospitalizations accounted for 24% of Medicare inpatient 
expenditures--approximately $2.5 billion per year (Anderson & Steinberg, 1984). 
Holloway, Thomas, and Shapiro (1988) added a statement about the findings of 
Anderson and Steinberg (1984) that since almost one-fourth of Medicare inpatient 
expenditures were for rehospitalizations, if a small fraction of such 
rehospitalizations were successfully prevented, there would be substantial savings 
for the Medicare Trust Fund (Holloway, Thomas, & Shapiro 1988).  
While the federal government was early interested in saving money by discharging 
patients to community services, hospitals had a financial incentive by encouraging 
patients to use their service. Thus, they were less motivated to measure explicitly 
what would happen to their patients post discharge. Acheson and Barr (1965) were 
pioneers in discussing rehospitalization as a measure of quality. The primary 
concern of their study was to adjust mortality rates by combining two discharges 
into a single discharge if they occurred soon after each one (a rehospitalization), 
instead of using simple discharge as the denominator for deaths soon after 
discharge (Acheson & Barr, 1965). The authors considered that rehospitalization 
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rate could be used as an index of the quality of medical care (Acheson & Barr, 
1965).  
In 1983, the Prospective Payment System (PPS) was introduced in the US to 
review healthcare utilization for hospitals (Iglehart, 1983). The PPS proposed a 
fixed amount regardless of the length of stay of a specific case to encourage 
hospitals to discharge patients as early as possible. As a result, some patients 
could be discharged prematurely that could lead to incomplete treatment, thereby 
increasing a subsequent need to return to the hospital (Williams & Fitton, 1988).  
To prevent premature discharge, in the late eighties, the US government mandated 
the Health Care Financing Administration (HCFA) to use early readmission as a 
quality indicator (Ashton, Kuykendall, Johnson, Wray, & Wu, 1995). The HCFA 
required Peer Review Organizations (PRO's) to inspect all Medicare records 
showing patients were readmitted within 7,15, and 31 days from discharge to figure 
out problems related quality of care (Silverman, 1988). Rehospitalization was used 
to identify the presence of quality problems for individual cases (e.g., premature 
discharge). Rehospitalization became useful for deducing quality differences 
among hospitals, physicians, or other types of providers. For example, if a hospital 
experienced higher rehospitalization rate than others had, the hospital could be 
considered as inferior quality of care.  
The Implementation of PPS led to a shift focusing on research and policy analyses 
about hospital readmissions. Literature was separately shifting into two main 
streams:  
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1. Examining if rehospitalization could be an indicator of quality of care  
2. Determining if rehospitalization rates served as a measure for hospital 
performance 
The first stream of research examined if rehospitalization could be an indicator of 
quality of care. There was a divergence in conclusions related to the link between 
rehospitalization and quality of care. While many authors indicated that 
rehospitalizations were associated with lower quality of care, others argued that 
rehospitalization should be a marker of healthcare utilization rather than quality of 
care.  
For example, an analysis of rehospitalization data of the U.S. Office of the 
Inspector General (OIG) found rehospitalizations did not significantly differ from 
other hospitalizations in the rate of unnecessary admissions, poor quality care, or 
premature discharge (Kusserow, 1989). Gronick et al., (1991) concluded that 
rehospitalizations after medical stays often indicated the progression of disease, 
rather than a discrete outcome of care, thus the analysis finding association 
between rehospitalizations and antecedent processes of care would require 
additional information not available from the Medicare data system (Gornick, 
Lubitz, & Riley, 1991). Thomas (1996) found no support for a hypothesis that 
patients who received poor quality of care during hospitalization would be more 
likely to be readmitted after discharge than those who received acceptable quality 
of care (Thomas, 1996). A review for articles published from 1991 to 1998 
concluded that an agreed-on method to adjust for confounders was necessary 
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because most rehospitalizations seemed to be found by unmodifiable causes and 
global rehospitalization rates were not useful indicator of quality of care (Benbassat 
& Taragin, 2000). Most recently, Fisher et al. (2014) conducted a systematic review 
to examine if rehospitalization rate as a valid quality indicator for hospital care. The 
group of authors in the study found no evidence for the validity of rehospitalization 
rate as a measure of quality of hospital care (Fischer et al., 2014). 
On the other hand, others explored that rehospitalizations were linked to poor 
quality of care during the prior hospitalization ((Riley & Lubitz, 1986); (Ashton et 
al., 1995); (Ashton & Wray, 1996); (Weissman et al., 1999)). Riley and Lubitz 
(1986), for example, stated that rehospitalization after a surgery was a significant 
measure of patient outcomes (Riley & Lubitz, 1986). Since it could be a sign of the 
surgery-related complications or continued care adverse event, rehospitalization 
rates could indicate important insights into outcomes and patterns of treatment 
(Riley & Lubitz, 1986). A case-control study determined whether the quality of care 
was associated with early rehospitalization within 14 days from discharge and 
found that lower quality of care increased the risk of early rehospitalization in 
patients with heart failure, diabetes, and obstructive lung disease (Ashton et al., 
1995).  
The second stream of research examined whether rehospitalization was a 
measure of hospital performance. Several studies indicated rehospitalization might 
not be a proper measure for comparing hospitals. Ashton et al., (1986) tested 
whether the adequacy of medical care during an inpatient period influenced the 
probability of rehospitalization in patients with chronic conditions. The authors 
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found discharge criteria related to inpatient care and transient to outpatient care 
were not useful for detecting deficiencies in hospital care (Ashton et al., 1986). 
DesHarnais et al., (1991) ranked 300 hospitals on each of three indices (i.e., Risk-
Adjusted Mortality Index, Risk-Adjusted Readmission Index, Risk-Adjusted 
Complications Index) and stated that there was no relationship between a 
hospital’s ranking on any one of these indices and its ranking on the other two 
(DesHarnais, McMahon, & Wroblewski, 1991). Weissman et al. (1999) found there 
were small differences in overall quality and the rarity of related adverse 
rehospitalizations as outcomes. Thus, they concluded that rehospitalizations were 
not useful tools for comparing quality among hospitals (Weissman et al., 1999). 
Ashton and Wray (1986) provided a conceptual framework that describes several 
causes of readmissions (see Figure 6) (Ashton & Wray, 1996). The figure 
illustrates how some causes led to readmissions and indicates that hospitalization 
rate may not be a good measure for quality of care. For example, a hospital with 
good quality of care can prevent adverse events that leads to fewer readmissions, 
but it can also prevent premature discharge that might lead less post-discharge 
deaths then generating more readmissions.  
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Figure 5. Framework for the association between premature 
discharges and early readmission  
  Source: (Ashton & Wray, 1996) 
From policy debate of understanding whether rehospitalization rate was a quality 
metric or a measure of patients’ health status, or just a measure of health service 
use, Kangovi and Grande (2011) proposed a broader framework to identify 
alternative strategies to reduce readmissions (see Figure 5) (Kangovi & Grande, 
2011). These authors pointed out that the current understanding of what led to 
rehospitalization was implicit. The framework of determinants of rehospitalization 
should be considered as a complete system including access, social determinants 
of health, and regulatory policies rather than just focusing on the quality of the 
inpatient discharge process and a patient’s health status. 
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        Figure 6. Framework of determinants of hospital readmission  
                                  Source: (Kangovi & Grande, 2011) 
As Figure 5, if health policy makers just rely on the current framework (A) to 
conclude that the best approach to reduce rehospitalization rates is to improve the 
discharge process for high-risk patients, they can forget other important factors. 
Per the broader proposed framework (B), hospitalization readmission rate is a 
measure of health service use. Hospital readmission is not only influenced by the 
quality of care and patients’ health status, but also associated with access to health 
services and to socioeconomic resources like income or social support.  
2.2. Measure for PHH 
2.2.1. Risk Factors 
The measure for PPHs found through the literature review comes from three 
largely separate literature areas: Literature on hospitalizations from the 
community; literature on hospitalizations from nursing homes; and literature on 
hospital readmissions (Maslow & Ouslander, 2012). All three areas generally 
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described hospitalizations as caused by several factors in the care provided for the 
patient in pre-and post-hospitalization period. These factors could come from a 
variety of places. Likewise, the measures of PPHs covering many of medical 
conditions (e.g., congestive heart failure, diabetes and pneumonia) were 
developed by different teams of clinicians, researchers, and policy analysts.  
Developing the measure of PPH is challenging because decision to hospitalize an 
individual depends on multiple factors, including financial incentives or 
disincentives in the current health care system. For example, decision to 
hospitalization for long-term care patients may depend on reimbursement policies 
or patient and family preference (See Figure 7)(Maslow & Ouslander, 2012). 
 
      Figure 7. Factors and Incentives influence the hospitalization 
                                Source: (Maslow & Ouslander, 2012) 
Thus, the measure for PPH must in some way account for these factors, which 
vary considerably for individual patients. Several measures primarily focus on 
patient populations with chronic diseases and specify one or more medical 
conditions that depends on the measure developers to be associated with PPHs. 
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For example, they are “hospital admissions for diabetes” or “hospital admissions 
for chronic cardiac conditions, including hypertension, heart failure, and angina 
without procedure”. UCSF-Stanford Evidence Based Practice Center in 2002 used 
the scientific literature and validation tests to arrive at a narrow set of 16 types of 
hospital admissions with Prevention Quality Indicator (PQI) conditions. For most 
types of initial PQI admission, Readmissions occurred across a wide variety of 
major disease categories: asthma, complications of diabetes, gastroenteritis, 
congestive heart failure (CHF), bacterial pneumonia, COPD, urinary tract infection, 
and hypertension.  
While the burden of COPD was clear and numerous studies have identified risk 
factors for PPHs for patient with COPD as well as interventions designed to reduce 
the readmissions, summarizing the study results has been difficult due to 
conflicting results across the studies as well as methodological variation among 
the studies. For instance, Bahadori and FitzGerald (2007) conducted a systematic 
review that indicated multiple potential modifiable factors were independently 
associated with a higher risk of COPD exacerbation requiring hospitalization 
and/or rehospitalization (see Table 2) (Bahadori & FitzGerald, 2007). 
No First author, 
Year 
Study design Risk factors Outcome 
 Hospitalization 
1 Kessler 1999 Prospective 
cohort 
Chronic hypercapnia 
respiratory insufficiency, 
pulmonary hypertension 
Hospitalization 
 
2 Garcia-Aymerich 
2000 
Cross sectional No rehabilitation, poor 
inhaler maneuvers, no 
Hospitalization 
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influenza vaccination, 
LTOT*, smoking 
3 Miravitlles 2000 Cross sectional FEV1* impairment, 
significant comorbidity 
Hospitalization 
4 Bourbeau 2003 Case control Inhaled corticosteroids Hospitalization 
5 Gadoury 2005 Randomized 
control trial 
Sex (female), increased 
walking distance, higher 
education, older age, 
reduced health status 
Hospitalization 
6 Garcia-Aymerich 
2001 
Case control Previous admissions, lower 
FEV*, LTOT* 
Hospitalization 
7 Wilkinson 2004 Prospective 
cohort 
Early therapy Hospitalization 
8 Soler-Cataluna 
2005 
Prospective 
cohort 
Older age, PaCO2 Hospitalization 
9 Miravitlles 2006 Cross sectional Use of LTOT*, increasing 
the number of previous 
exacerbations, short acting 
beta-2 agonists, incomplete 
primary education, 
impairment in health status 
Hospitalization 
 Rehospitalization 
 
10 Pouw 2000 Case control Low BMI on admission, 
Weight loss during 
hospitalization 
Rehospitalization 
11 Lau 2001 Retrospective 
cohort 
Pre-hospital admission, 
length of stay >5 days, 
nursing home residency, 
self-care activities, right 
heart strain pattern on 
ECG*, inhaled 
corticosteroid, bicarbonate 
level >25 mmoll-1 
Rehospitalization 
 
12 Groenwegen 
2003 
Prospective 
cohort 
Younger age, long-term oral 
corticosteroid 
Rehospitalization 
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13 Garcia-Aymerich 
2003 
Prospective 
cohort 
Physical activity Rehospitalization 
 
14 Gudmundsson 
2005 
Prospective 
cohort 
Anxiety, low FEV1*, low 
health status 
Rehospitalization 
 
15 Wang 2005  Retrospective 
cohort 
Living alone, frequency of 
COPD exacerbation, not 
having a family doctor 
Rehospitalization 
 
16 Connolly 2006 Prospective 
cohort 
Previous admission, poor 
performance 
Rehospitalization 
 
17 Cao 2006 Cross sectional Disease duration >5 years, 
FEV1* < 50% predicted, 
use of psychotropic drugs, 
vaccination status 
Rehospitalization 
 
*LTOT: Long Term use of Oxygen Therapy; BMI: Body Mass Index; FEV1: Forced Expiratory 
Volume; 
 ECG: Electrocardiogram 
 
 
             Table 2. Risk factors for HL and re-HL outcomes  
                           Source: (Bahadori & FitzGerald, 2007) 
Many studies, however, showed the COPD related-risk factors for hospitalizations 
and rehospitalizations were divergent across the studies. While a retrospective 
study reported that comorbid conditions (ECG, coronary artery disease, left 
ventricular failure, diabetes mellitus) and corticoid drug use were significant risk 
factors for early hospitalization (Lau, Yam, & Poon, 2001), a case-control study 
found that there was no influence from inhaled corticosteroids, even at moderate 
to high doses, on rehospitalization for COPD exacerbation (Garcia-Aymerich et al., 
2001). In terms of demographic factors, on the one hand, female gender was noted 
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as a risk factor for reduced hospitalization in a multicenter, randomized controlled 
trial (Gadoury et al., 2005) and older age was considered as a risk factor for 
hospitalization in a prospective study (Soler-Cataluña et al., 2005). On the other 
hand, Garcia-Aymerich et al.,(2001) indicated neither age nor gender was found 
to be related to hospitalization for COPD patients in a case-control study (Garcia-
Aymerich et al., 2001). Age also was not associated with an increased risk of 
rehospitalization in a prospective study (R Kessler, Faller, & Fourgaut, 1999). The 
negative association between smoking status and hospitalization was described 
by (Anthonisen, 2000).   
2.2.2. Time Interval for PPHs  
The U.S Patient Protection and A ordable Care Act (ACA) considered preventable 
hospitalization as a target to improve patient care and healthcare cost savings in 
2010. CMS released the Hospital Readmissions Reduction Program (HRRP) in 
2012, originally focusing on heart failure, pneumonia and acute myocardial 
infarction. By collaborating with  a team of clinical and statistical experts from Yale 
and Harvard Universities, CMS generated the 30-day risk-standardized 
readmission measures based on inputs from multiple national Technical Expert 
Panels and public comments (Centers for Medicare and Medicaid Services, 2014). 
Annually, CMS has maintained the readmission measures and recomputed the 
rates to obtain responded updates from public comments and policy 
considerations.  
While CMS calculated several health-related indicators, 30-day readmissions are 
the only indicator used to reduce payment measuring of health utilization, rather 
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than directly measuring of patient health. A 30-day period is considered being the 
maximum period that hospitals can reasonably be held accountable for problems 
in the quality of inpatient care that leads to a readmission. Many studies, however, 
have addressed that readmissions occurred within various time intervals between 
the first and subsequent hospitalizations. Berkman et al., (1987) defined “early 
recurrent readmission” for a related-cardiac diagnosis as readmission to any acute 
care hospital with a related-cardiac diagnosis within 4 months of discharge from 
Massachusetts General Hospitals (Berkman, Dumas, Gastfriend, Poplawski, & 
Southworthe, 1987). Holloway et al., (1988), used a readmission within 60 days of 
discharge as the index hospitalization (Holloway, Thomas, & Shapiro, 1988). A 
study using a national random sample from Medicare Provider Analysis Review 
data and the Continuous Medicare History Sample data calculated the probability 
of rehospitalization for any reason within 30 days and 365 days following an index 
discharge. The study found the probability of rehospitalization within 30 days was 
18.2% and within 365 days was 53.3% (Anderson et al., 1990). Corrigan and 
Martin (1991) considered that the "number of readmissions" was the total number 
of admissions during the 365-day period subsequent to the index episode used to 
identified initial hospitalization (Corrigan & Martin, 1992). Depending on conditions 
and populations studied, a recent review article concluded that a fraction (less than 
half) of readmissions within 90 days were associated with substandard care from 
the first admission (Benbassat and Taragin 2000).  
Recently, Jencks et al., (2009) found the 19.6% rate of rehospitalization within 30 
days after discharge reported for Medicare beneficiaries in 2003-2004 was 
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consistent with the rate in MedPAC’s 2008 report of 2005 data (17.6% at 30 days), 
and the different rate reflects methodologic differences rather than a temporal 
trend (Jencks, Williams, & Coleman, 2009). Jencks et al., (2009) also pointed out 
rehospitalization rate at 60 days was 31% when they analyzed data in the same 
way as Anderson et al., (1984) who reported a rate of 22.5 % at 60 days for the 
1976-1978 period (Anderson & Steinberg, 1984); (Jencks, Williams, & Coleman, 
2009). This large difference was more likely to indicate an actual increase in 
rehospitalization rate over time. Jencks et al., (2009) suggested that further studies 
would need to understand the 30-day measurement and risk of failures in 
discharge planning, insufficient outpatient and community care, and severe 
progressive illness. In addition to 30 day readmission rates, Kangovi and Grande 
(2011) suggested monitoring 90 and 180-day rates, emergency department and 
observation service use, and mortality (Kangovi & Grande, 2011). Long time 
intervals after the initial hospitalization decreased the risk of a rehospitalization 
related to the clinical care or discharge planning in the initial hospitalization and 
increased the relative importance of outpatient management of chronic illness 
(Hannan et al., 2017). 
In practice, different decision rules can inform which rehospitalizations are 
potentially preventable. The rules could be narrow that identify only 
rehospitalizations with nearly certain avoidable, such as complications resulting 
from a perforation during surgery. Alternatively, they could be broader that 
determine a variant type of rehospitalizations with likely preventable, such as 
rehospitalizations for COPD after cardiac surgery—some of which may be avoided 
32 
 
if COPD medications are appropriately adjusted at discharge. Healthcare Cost and 
Utilization Project (HCUP) of the Agency for Healthcare Research and Quality 
(AHRQ) described 12 most common measures of patient rehospitalization in a 
recent report (Barrett, Raetzman, & Andrews, 2012). Each measure has different 
criteria for determining the initial hospitalization and rehospitalization. One study 
using Massachusetts data compared rehospitalization rates measured from three 
different measures including the 3M, the UnitedHealth, and CMS measure. This 
study showed a wide range of derived rehospitalization rates from the 8.5 percent 
for the 3M measure to 19.3 percent for the UnitedHealth measure and 21.9 percent 
for the CMS condition-specific measures (Boutwell & Jencks, 2012).   
2.3. Penalty for excessive PPH related to COPD 
There is evidence that readmission rates are too high in the United States and can 
be lowered. Historically, almost 19 percent of Medicare discharges were followed 
by a readmission within 30 days (Jencks, Williams, & Coleman, 2009).The Hospital 
Readmission Reduction Program (HRRP) of CMS that required a reimbursement 
penalty for excess readmissions following index hospitalizations included COPD 
as a part of program in October 2014 (Feemster & Au, 2014).  
Beginning in October 2014, hospitals have been evaluated on their performance 
based on the ability to reduce 30-day-all-cause-unplanned readmissions for 
COPD. CMS would penalize hospitals if hospitals had readmission rate above the 
national average rate after adjustment for patient case-mix (Centers for Medicare 
and Medicaid Services, 2014). Despite the potential benefits from HRRP are clear, 
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there are a number of concerns for the CMS method (Feemster & Au, 2014). The 
CMS method assumes that high quality care is possible to reduce readmission 
rates. But, for COPD patients, there was no clear linkage between quality of care 
and 30-day hospital readmission rates and widely studied interventions for COPD 
exacerbations that have significantly reduced readmission rates (Prieto-Centurion 
et al., 2014). In addition, there is unclear that reduction of readmission rates is 
neither benefit nor harm overall health status and outcomes for patients with 
COPD. Furthermore, COPD exacerbations, a high risk factor of readmission, are 
influenced by socioeconomic status (SES) (Eisner et al., 2011). Sjoding and Cooke 
(2015) found that hospitals with the highest percentage of low-SES patients were 
more often among hospitals with high COPD readmission rates. Because of the 
finding, the study suggested that hospitals caring for disadvantaged populations 
are more likely to be penalized for high COPD readmission rates (Sjoding & Cooke, 
2015).  
A National Quality Forum working group convened at the request of the federal 
government recently recommended that CMS should include socioeconomic 
factors in the risk adjustment of hospital performances measures (National Quality 
Forum, 2015). Currently, CMS monitors the impact of SES on readmission rate 
and collaborates with the National Quality Forum in a two-year trial to test 
sociodemographic factor risk adjustment with approximately 300 measures 
reviewed (National Quality Forum, 2017a). CMS will evaluate the results and 
present in the CMS reports to Congress and related Secretarial recommendations 
when they are available (CMS-163-F).  
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However, several authors have concerned whether the new adjustment methods 
will be adequate or remains unclear. Currently, hospitals caring for socially 
vulnerable patients will continue to receive penalties for factors outside their 
control. Furthermore, some believe that pay-for-performance measure may 
unfairly penalize hospitals that treat underserved patients, thereby increasing 
ethnic disparities. Some believe that both penalizing hospitals with above average 
readmission rates and giving bonuses to hospitals with low readmission rate may 
be a better option for the goal of readmission reduction.  
2.4. Current predictive approaches for hospitalizations and 
rehospitalizations 
Various quality improvement interventions have been created, such as peer 
advisors pre-and post-discharge, disease management program administered by 
home health nurses, and enrollment in rehabilitation program, to reduce the risk of 
readmission and improve outcome for patients. There are many reasons causing 
patients to return to hospitals. To get success of implementing the interventions, it 
is required an understanding of the patient characteristics (e.g., patient 
demographics and health status) associated with hospitalization or 
rehospitalization that will help physicians stratify patients regarding to specific 
hospitalization-related risks and assist in designing for pre-and post-discharge 
plans. In practice, although it is not easy for a model covering all factors 
contributing to risk of hospitalization, admitted or readmitted patients do share 
certain characteristics that can serve as potential parameters to fit into the 
predictive model. A 2012 survey from Health Intelligence Network indicated that 
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predictive modeling was one of the most popular tools used to identify patients at 
risk for rehospitalization (see Figure 8) (Matthews, Donovan, & Salmon, 2014).  
 
              Figure 8. Identifying individuals for readmissions 
Source: HIN reducing hospital readmissions in 2012 survey     
(Matthews et al., 2014) 
In a systematic review identified all studies published between 1950 and 2007, 
authors reported that a variety of data sources, analytic approaches, and outcome 
measures were used to determine patient-related factors for rehospitalization 
(Desai, Stauffer, Feringa, & Schreiner, 2009). The authors indicated most studies 
(89%) relied on medical record review or patient interview, just 11% used 
administrative database. There were approximately 47% of the studies used all-
cause rehospitalization as an outcome and 23% used the composite outcome of 
disease-related rehospitalization or death. In addition, while half of the reviewed 
studies used unadjusted analyses to identify significant predictor variable, others 
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favored logistic regression. None of them included a C-statistic or other measure 
of model performance. As a result, there is little consistency in the covariates and 
reliability in the used models. Since few studies provide information about 
important risk predictors for rehospitalization, it is impossible to compare the final 
findings from models among the reviewed studies. 
Another systematic review for studies from March 2011 to August 2011 indicated 
that most readmission prediction models performed inaccurately that raised 
concerns about the standardization of readmission risk across hospitals to equally 
compare hospital performance (Kansagara et al., 2011). Authors found all three 
models conducted by CMS showed poor performance in prediction for 30-day all-
cause readmissions (i.e., C-statistic equals 0.61 for congestive heart failure, 0.63 
for acute myocardial infarction, and 0.63 for pneumonia) (Kansagara et al., 2011). 
Regarding to covariates, the authors indicated nearly all reviewed studies included 
comorbidity data, prior use of medical services, basic sociodemographic variables. 
Clinical data from medical records or registries did not improve performance of  the 
CMS models with only claims data  (Kansagara et al., 2011). In addition, the 
authors suggested identifying broader social, environmental, and medical factors 
such as access to care, social support, and system-level factors that may 
contribute to the risk of hospitalization. This suggestion is consistent with the 
framework of determinants of hospital readmission proposed by Kangovi and 
Grande (2011) (Kangovi & Grande, 2011). 
CMS has a congressional mandate to evaluate hospital performance using risk-
standardized mortality, process of care outcomes, and risk-standardized 
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readmission rates. Since the outcomes need reflect something directly affected by 
the quality of care, the rehospitalization rates are required adjusted patient-mix, 
the distribution of indications for rehospitalization in a patient population, if they are 
used to infer quality of care. The patient-mix adjustment model is an essentially 
standardization technique. A logistic regression model is used to predict 30-day 
readmission risk based on some few recognized risk factors from literature (e.g., 
age and sex), and scaled the crude readmission rate at each hospital by the 
predicted readmission risk for all the hospital’s patients. Despite the power of 
logistic regression on binary outcome prediction, a common problem with logistic 
regression occurs as a logistic model perfectly or nearly perfectly predicts the 
outcome, so-called complete or quasi-complete separate problem. A 
recommended solution for this problem could be trying to reduce the perfectness 
of model fit by decreasing the number of variables in the model, categorizing 
continuous variable, or merging categories of categorical variables. It, however, is 
challenging with larger dataset, because it is hard to know exactly which variables 
cause the separate problem.  
Recently, CMS applied Markov chain Monte Carlo (MCMC) estimation to fit the 
hierarchical random effect parameters in the model. MCMC approximates the 
distributions of all model parameters (fixed and random effects) by sequentially 
sampling from conditional distributions. The approach requires the use of good 
starting values to ensure model convergence and execution of more than one 
chain to assess model convergence.  
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Alexandrescu et al., (2011), however, applied the hierarchical model for 
examination of the effect of data clustering on a binary outcome (no 
hospitalization/hospitalization), then found the study model was associated with 
convergence problems (Alexandrescu, Jen, Bottle, Jarman, & Aylin, 2011). The 
Committee of President of Statistical Societies released a report which criticized 
the CMS adjustment technique on several points, noting that more sophistical 
techniques such as data mining techniques (e.g., Boosting and Random Forest) 
should be considered to properly adjust for confounding (Ash, Fienberg, Louis, & 
Normand, 2012). Particularly, the group of authors stated that classification 
prediction of a binary dependent variable (no readmission / readmission) could be 
handled very well by type of ensemble decision trees like Random Forest. For 
model performance evaluation, the authors recommended using C statistics or a 
variety of sensitivity analyses. Lastly, they considered that other approaches such 
as empirical Bayes or generalized estimating equations (GEEs) would be more 
easily communicated than the current CMS approach (Ash et al., 2012). 
2.5. Random Forest - A Technique of Machine Learning  
Recently, it is increasing the interest of data mining application in doing research 
in health care. Data mining is a powerful method of exploring large amounts of 
data to build knowledge and discover unknown patterns or relationships that can 
be applied hospitalization and/or rehospitalization prediction. The concept of data 
mining emerged in middle of 1990’s as a new method for data analysis and pattern 
discovery. Yoo et al., (2012) pointed out four main points that make data mining 
different from statistics (Yoo et al., 2012).  First, statistics usually use conservative 
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analysis strategies but methods in data mining are more flexible. Second, while 
statistics uses a sample of data extracted from population, data mining uses data 
covering the entire population. Third, while statistics only handle numeric data, 
data mining can deal with multiple kinds of data (e.g., images, text, number…). 
Lastly, while statistics build hypothesis and then use collected data to test the 
hypothesis, data mining can explore hidden patterns from collected data without a 
hypothesis.  
Various machine learnings can be applied for data mining to address some 
problem like hospitalization and/or rehospitalization prediction. Classification and 
Regression Tree (CART) is one of common machine learnings used  the tree-
building algorithms to determine classification of outcomes or obtain accurate 
prediction (see Figure 9) (Speybroeck, 2011). Tree method is non-parametric, so 
it does not require prior assumption about the distributions of the variables and the 
association among the variables. Thus, it is a good tool for data mining purposes. 
CART, however, has some limitations. For example,  the decision tree can be too 
complex (i.e., large and deep tree) to be interpreted when a data set contains many 
variables and a common problem with classification trees is over-fitting (Yoo et al., 
2012). 
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    Figure 9. Example of Classification Trees  
(a) Depict how to separate observations of the example data by   education and 
income. (b) Apply CART to classify. Source: (Speybroeck, 2011) 
Random Forest (RF) was first created by Leo Breinman (L. Breiman, 1999). As the 
name implies, it uses random bootstrap samples of the original sample to construct 
and ensemble multiple classification trees building a “forest”. The rationale behind 
RF is that multiple classification models working together, thereby yielding better 
classification accuracy than the use of a single model. Moreover, RF can 
accommodate thousands of attributes, maintain accuracy even when a large 
proportion of data are missing, and avoid over-fitting possibility. RF has been 
demonstrated to be one of the most accurate machine learnings and capable of 
generating a rank of variable importance (Ward et al., 2006).  
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Several studies demonstrated that the RF approach could improve classification 
performance in the biomedical and healthcare field. For example, a study 
compared RF with other well-known algorithms (i.e., Classification-Tree CERP; 
Classification and Regression Tree; Logistic Regression Tree CERP; Boosting; 
Decision Forest; Support Vector Machine; Diagonal Linear Discriminant Analysis; 
Shrunken Centroid; Classification Rule with unbiased interaction selection and 
estimation; Quick, Unbiased and Efficient Statistical Tree) applied for personized 
medicine (Moon et al., 2007). The authors found RF outperformed the others in 
classifying for the lymphoma data and the breast cancer genomic data. Another 
study developed models to predict the bleeding source and identify the cohort 
among patients with acute gastrointestinal bleeding who required urgent 
intervention. The study results indicated that the RF models consistently showed 
the best performance in comparisons with Artificial Neutral Networks, K-Nearest 
Neighbor, Decision trees, Support Vector Machines, and Shrunken Centroid (Chu 
et al., 2008). Ward et al., (2006) applied RF to identify the most important 
predictors for short-term prediction of mortality in patients with systemic lupus 
erythematosus and they found RF represented a useful technique to identify the 
most important predictor from large number and to validate the classification (Ward 
et al., 2006). 
Considering outperformance of RF for classification and prediction in practice, this 
study relies on the RF model to determine risk factors related with hospitalization 
or rehospitalization for patients with COPD and predict which patients are at high 
risk for hospitalization or rehospitalization.    
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Chapter 3. CONCEPTUAL FRAMEWORK 
Chapter 3 briefly depicts the conceptual framework of this study based on the 
concept of Chronic Care Model (CCM). This chapter begins with some challenges 
for health care due to the growth of chronic diseases. Next, two common concepts, 
disease management and integrated care management, are discussed in a context 
of dealing with the challenges of chronic diseases. Then, we present Chronic Care 
Model and evidence of applying this model in practice as well. Finally, this chapter 
provides a summary of some gaps existing in literature for the CCM application. 
3.1. Challenges for healthcare systems  
Health care systems are facing the pressure of increasing burden of chronic 
disease. There are, however, several key factors contributing to the growth of 
chronic disease burden related to both patients (i.e., aging and life-style) and 
healthcare system factors (i.e. efficiency of care delivery, coordination of care, and 
quality of care). To determine the most important factors, policy makers and health 
practitioners must consider the health care landscape and society linked as an 
integration of one setting.  
From the perspective of integration of health care and society, identified factors 
must be in a context that will recognize the influence of one on another. For 
example, the aging of population contributes to higher rates of chronic disease 
beside lifestyle (e.g., diet and smoking). Then, a combination of the aging and life-
style factors can even increase incidence of chronic disease faster. For the factors 
related to health care, advances in treatment for chronic illness can lead to more 
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people being diagnosed with disease or cured for many acute illnesses that helps 
to extend life expectancy, thus raising the chance for a chronic disease 
development.  
In the 1900s, while infectious diseases such as tuberculosis, diphtheria, and 
bronchitis were the leading causes of death, chronic disease just accounted for 
less than 20 percent of deaths. Currently, chronic diseases account for than 80 
percent of death (Steinbrook, 2006). A survey of older Americans conducted in 
2005 estimated approximately 80% of people over 50 years of age living with at 
least one chronic condition (see Figure 10) (Johns Hopkins Bloomberg School of 
Public Health, 2005).  
 
                     Figure 10. Chronic illness among older Americans  
           Source: (Johns Hopkins Bloomberg School of Public Health, 2005) 
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Chronic conditions generate more challenges in disease management and 
intervention. Patients with chronic illnesses receive treatment for several 
conditions and thus must take a combination of multiple medications. Multiple 
medications may be associated with substantially lower adherence, further leading 
ineffective treatment due to drug interaction (Marcum & Gellad, 2012). In addition, 
chronic illness challenges patients with a range of needs that increase 
responsibility for patient self-management. Patients may experience worsening of 
one condition by treatment of another. For example, a patient with chronic 
respiratory disease may struggle to adhere to exercise programs designed for their 
diabetes. 
Due to the challenges, chronic conditions require a response that involves 
coordinated inputs from all parts of health care system such as health 
professionals, access to health service, or access to medication. Healthcare, 
however, is still mainly built to address an acute and periodic model of care; thus, 
it cannot meet the requirements of chronic diseases. Consequently, patients with 
chronic diseases turned out untreated or poorly cared conditions until exacerbation 
arise. For example, there was an estimate that patients with COPD received only 
55% of recommended care (Mularski et al., 2006). The goals of chronic care are 
not to cure but to improve functional status, minimize distressing symptoms, 
prolong life, and enhance quality of life. A model of care for chronic conditions 
needs to consider a patient-centered approach with all factors indirectly or directly 
related to patient, healthcare personnel, community, and health care service to 
optimize health outcomes. Without deeply understanding of the factors, it is difficult 
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to define the best model. In addition, each model highly depends on a context that 
the factors must work at the same time to optimize outcomes and can have a quite 
different role in another model. Therefore, many models are evaluated as “black 
boxes” about the critical factors for success or failure. 
3.2. From disease management to integrated care management 
Disease management has traditionally targeted patients with a single disease or 
condition. In 1980s, disease management was first mentioned as a concept in the 
U.S and initially used by pharmaceutical companies offering educational programs 
to employers and managed care organizations to promote medication adherence 
and behavior change among patients with chronic conditions such as diabetes, 
asthma and coronary artery disease (Bodenheimer, 1999). Recently, disease 
management concepts were considered as an approach aimed to provide better 
care for patients with chronic conditions while reducing health care service that 
leads more cost-effective for health care (Health Policy Institue, 2014).  
There are two key trends emerging in disease management (Nolte & McKee, 
2008). First, a variety of programs operating under the label “disease 
management”. The programs focus on specific processes of care or clinical 
outcomes, patient education and self-management based on information systems. 
Typically, the programs (e.g., cost-containment strategy) are created by 
commercial for-profit vendors and promoted to health insurers (Bodenheimer, 
2000). Secondly, there has been a trend towards developing a broader population-
based approach that shifts to address the multiple needs of patients with 
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comorbidities and multiple conditions (Geyman, 2007). Since the development of 
disease management reflects the situation with integrated care, there is a wide 
range of definitions of disease management that varies in scope, focus, purpose 
and range of component interventions. Definitions range from discrete programs 
focused on costs reduction and outcomes improvement for patients with specific 
conditions to a population-based systematic approach that identifies persons at 
risk, measures the outcomes, and provides quality interventions.  
In conclusion, although there is considerable overlap between concept of 
“integrated care” and “disease management”, there are some differences between 
two of these concepts. While the concept of integrated care regularly links with 
social care sectors, the disease management is normally limited to relationships 
within healthcare sectors. To address the needs of patients with chronic conditions, 
there are many frameworks and models of both “integrated care” and “disease 
management” developed since the 1980s. However, since the patient care process 
is unlikely to follow a single path, the model variation seems to be inevitable. Thus, 
a key challenge for healthcare system facing with chronic disease is that uncertain 
factors and boundaries among them are not always easy to define.  
3.3. Chronic Care Model (CCM) 
There has been an increase in developments of disease management targeted to 
deal with major chronic illnesses. In disease management program, planned care 
requires doctors to shift intellectual thinking and worrying about specific patients 
to considering clinical features or needs and how those needs might be met. This 
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shift is facilitated by guidelines based on scientific evidence of effectiveness. The 
so-called evidence-based programs should be improved by working within a care 
system that values guidelines and creates a plan at the organizational level to 
assist practitioners to comply with guidelines ( see Figure 11) (Wagner, Austin, & 
Korff, 1996).  
 
    Figure 11. Improving outcomes in chronic illness 
          Source: (Wagner et al., 1996) 
The model in Figure 11 attempted to summarize the general features to improve 
chronic illness care. To improve the model, the role of community and patient self-
management need to be added on the model (Wagner, 1998). Thus, CCM was 
created by adding community and self-management related features. CCM is 
based on the idea that high-quality chronic care is derived by productive 
interactions between the practice team and patients. The interactions include 
assessment, self-management support, optimization of therapy and follow-up. 
Drawing on a synthesis of the evidence of effectiveness of various chronic disease 
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management interventions, CCM consists four interacting system components 
considered providing good chronic care: self-management support, delivery 
system design, decision support and clinical information systems. These four 
components  are placed in a health system context connecting a delivery system 
with community resources and policies (Figure 12) (Wagner, 1998) .  
 
                Figure 12. The Chronic Care Model  
         Source: (Wagner, 1998) 
Healthcare organization refers to a practice organization. It includes support and 
promotion of the chronic disease improvement. Organizational support is the 
concept that addresses the culture of the practice as well as system leadership. In 
the ideal practice, leadership is committed and visibly involved, supports change 
and quality improvement, and creates incentives for providers and patients to 
improve care and adhere to evidence-base practice.  
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Practice improvement is not possible without data on trends in individual patients 
and the health of the practice population. Clinical Information systems are 
structured to organize patient, population, and provider data to describe the health 
of the population and to facilitate efficient and effective care. Clinical information 
systems should provide information about individual patients as well as data 
regarding populations of patients. The system should include a disease registry 
that identifies the population and includes information about provider performance 
of guidelines. In CCM, the information system may also include a registry regarding 
patient-specific needs and reminder systems that may be able to generate 
treatment planning to facilitate care or self-care.  
Delivery system design addresses the composition and function of the practice 
team, the organization of visits, and the management of follow-up care. The 
delivery of effective, efficient clinical care through appropriate use of all team 
members, planned patient interactions, regular follow-up, and case management 
are important parts of delivery system design. Therefore, practice improvement 
programs that optimize team members need to assure that all team members are 
visible to the patient.   
Decision support includes mechanisms for increasing provider access to evidence-
based practice guidelines and to specialists for collaboration; and may include 
system prompts and reminders. Like the research literature studying clinical 
information systems, studies support the effectiveness of a variety of decision 
support interventions in improving the process of care delivery, but research on 
improved clinical outcomes is less robust.                               
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A critical component of the CCM model is self-management support, emphasizing 
the need for patient-centered interventions. These interventions can include 
tailored education resources, skills training, psychosocial support, and 
collaboration between provider and patient to define problems, establish goals, 
identify barriers, create treatment plans, and solve problems. The target of self-
management support is to encourage patients to manage their health. Developing 
self-management skills can have a positive effect on health outcomes of people 
with chronic illnesses.                                                                           
The final component of CCM is community resources. The model acknowledges 
the importance of linkages with the community for peer support, care coordination, 
and community-based interventions. Community-practice partnerships are 
especially important with elders, low-income, and underserved populations.  
3.4. Evidence of CCM  
Bodenheimer et al. (2002) reviewed studies of diabetes care programs that 
featured components of CCM (Bodenheimer, 2000). The most frequent 
interventions used in the programs were patient education and training (CCM 
component: self-management support); educational materials and meetings for 
physicians (CCM: decision support); use of case managers, multidisciplinary 
teams and scheduling of planned visits (CCM: delivery system design); and 
reminder systems and feedback on physician performance (CCM: clinical 
information system). Out of 39 studies, 32 studies found the intervention was 
improved at least one process or outcome measure. However, the authors noted 
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difficulties in establishing a direct relationship between the number of CCM 
components and/or specific combinations of CCM components and overall 
effectiveness.  
Focusing particularly on the primary care setting, Zwar et al. (2006) recently 
examined the evidence on the effectiveness of the six CCM elements (Zwar et al., 
2006). Using a systematic review and a review of reviews, they identified a series 
of key elements and interventions shown to be effective for selected process and 
outcome measures, as summarized in Figure 13. 
 
Figure 13. Summary of evidence on effectiveness of CCM 
           Source : Zwar et al. (2006)  
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Zwar et al. (2006) found the elements influencing most consistently on clinical and 
patient outcome measures were self-management support and delivery system 
design. There, however, was little evidence on the impact of other components 
involving healthcare organization and/or community resources. Although CCM has 
been widely embraced as key to effective chronic disease management, the 
findings of Zwar et al., (2006) agreed with the study results of Singh and Ham 
(2006) in a statement that the impact of CCM as an integrated setting is scarce 
(Singh & Ham, 2006). 
Recently, the entire CCM model has been evaluated. For example, Piatt et al., 
(2006) used an experimental design to assess the impact of CCM on clinical and 
behavior outcomes of patients with diabetes in a small sample of primary care 
practices in an underserved area of Pittsburgh, Pennsylvania (Piatt et al., 2006). 
After 12 months of follow-up, the study found marked improvements for two of the 
clinical outcomes and for self-monitoring of blood glucose in the CCM group 
compared with two other groups but all other outcome measures were not 
significantly improved.  
3.5. Summary 
In summary, as judged by the published literature, an evidence gap remains 
regarding the impact of applying CCM as an integrated system on quality of care 
and patient outcomes. A few studies applied CCM have focused on patients with 
coexisting conditions or multiple health problems, even though this is rapidly 
increasing in a variety of patient populations. In addition, research has only 
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concentrated on short-term outcomes, relatively little is known about the long-term 
impact of CCM for chronic disease management. Moreover, while a disease 
management intervention that adopts CCM may generate a great effect on patient 
outcomes, it seems likely that the implementation of a single intervention in 
isolation is not sufficient to improve the quality of chronic illness care. Importantly, 
available evidence suggests that the impact of chronic disease management 
interventions depends on the specific features of the healthcare setting. Based on 
the reviews of CCM, this study uses the concept of CCM to address the research 
question whether a combination of factors related to health utilization and patient 
health status contribute to predict hospitalization and/or rehospitalization for 
patients with COPD. 
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Chapter 4. METHODS 
Chapter 4 constitutes the methodologic pillar of the thesis, in which the study 
design is outlined, the study cohort construction is described, and the main 
statistical method, Random Forest models, is defined. First, this chapter outlines a 
figure of study design and describes a plan with multiple steps on how to construct 
the study cohort from the data source, insurance claim data sets. Next, this study 
proposes to formalize two different study designs to construct the analytical 
samples for each aim of this study, that are a nested case-control study for 
hospitalization prediction and prospective cohort study for rehospitalization 
prediction. This chapter then discusses the algorithm of Random Forest for 
classification and the optimization of model parameters. Finally, Chapter 4 
discusses how to derive the Random Forest technique to fulfill the specific aims of 
this study.  
4.1. Database and cohort design 
4.1.1. Database description 
This study uses claims data from a single, large, Midwestern, self-insured 
employer group using a third-party administrator for health benefit management. 
The final dataset included records for 8,085 employees and their dependents, all 
having the same employer-sponsored health insurance plan from Jan. 1, 2010 until 
Dec. 31, 2013.  
The dataset is created from three claims files: Pharmacy, enrollment, and medical 
claims. The enrollment file includes demographic information (e.g., year of birth 
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and gender), the medical file contains information related to medical encounters 
(e.g., disease diagnosis and medical procedures), and the pharmacy file contains 
information about all pharmaceuticals and other medicine prescribed and billed 
through insurance benefits to patient (e.g., drugs administered during an office visit 
and medical supplies provided to patient).  
For each member record in the enrollment file, the disease diagnosis can be 
identified for the medical visit and what medical actions were taken in the medical 
file, what medicine or other pharmaceutics were prescribed in the pharmacy file. 
The three of the files shares the same unique member identification number 
(Unique ID) that allows linkage of the files together to create a longitudinal health 
services record.  
The study documents were approved by the Institutional Review Board (IRB), 
University of Minnesota on Dec. 23, 2015 (see Appendix 1). Figure 14 describes 
the structure of the data files and how patient information related to patient 
demographic, health utilization and health status is extracted out for this study. 
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     Figure 14. The Structure of the data files 
         ICD: International Classification of Disease 
        NDC: National Drug Code; GPI: Generic Product Identifier 
4.1.2. Study time frame  
The study time frame is from Jan. 1, 2010, to Dec. 31, 2013. The study establishes 
a 12-month Pre-observational period from Jan.1, 2010 to Dec.31, 2010. The 12-
month pre-observational period is aimed to ensure sufficient time to observe risk 
factors that are relevant to the risk of hospitalization. For hospitalization event, the 
hospitalization period of a nested case-control study used to detect hospitalization 
events begins from Jan.1, 2011 to Dec. 31, 2013. For rehospitalization event, the 
rehospitalization period of a prospective study used to follow up for identifying 
rehospitalization event begins from Jan. 1, 2010 to Dec. 31, 2013. 
Figure 15 shows an outline of study design and time frame to create the analytic 
samples for hospitalization and rehospitalization prediction. 
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       Figure 15. The study design and time frame 
4.1.3. Construction of study cohort and analytic samples for modelling 
To build the predictive models of hospitalization and rehospitalization risk, the 
datasets are pre-processed in several steps, using SAS 2016 ®. The goal of this 
data pre-processing procedure is to clean the data, to select part of the data 
relevant for the predictive modelling, to define the predicted outcomes in the 
analyses (i.e., hospitalization and rehospitalization) and the predictor variables. 
This procedure is carried out through the following four steps as Figure 16.  
Step 1. Build study cohort 
Patients are included in this study cohort: 
 If they are at least 18 years of age and diagnosed with COPD. 
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 A patient has a diagnosis of COPD, as determined by a primary or secondary 
diagnostic code related to COPD. By following the CDC definition for COPD (CDC, 
1998), the International Classification of Diseases, 9th Revision, Clinical 
Modification [ICD-9-CM] codes for COPD are included:  
490: Bronchitis, not specified as acute or chronic 
491: Chronic bronchitis 
492: Emphysema 
494: Bronchiectasis 
496: Chronic airway obstruction 
 Patients are required a continuous enrollment in medical and pharmacy 
benefits in the 12-month periods.  
 Step 2. Allocate subsets with and without hospitalization 
After all patients are identified for the study cohort, the study cohort will be divided 
into two subgroups: a subgroup of patients with hospitalization and another of 
patients without hospitalization.  
The place of service code (POS) is usually used on medical claims to specify 
where health service was performed. As the POS set of CMS, the inpatient service 
code is 21 (CMS place of service code set).  CMS uses a 24-hour period or two 
more midnights staying in as criteria for qualified hospitalizations (CMS reports, 
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2008 & 2014). Claims database, however, does not always include a timestamp to 
determine the hospital events as same as the CMS description.  
Thus, a hospitalization in this study is determined as patient’s encounter shows 
POS related to inpatient service (i.e., POS = 21) and admission date is not the 
same as discharge date. 
 
60 
 
   Figure 16. Inclusion and exclusion criteria outline  
         POS abbreviated for “Place of Service” 
        HL for Hospitalization; Re-HL for “Rehospitalization” 
Encounters representing inpatient visit based on the POS code are marked as the 
study outcome. The initial inpatient service is identified by the encounter with the 
earliest admission date.  
The hospitalization subgroup is a subset of the study cohort and includes all 
subjects with the initial inpatient service. Patients in the hospitalization subgroup 
are excluded if: 
 Missing patients’ demographic information. 
 Encounters indicate that the POS equals 21 but the dates of admission and 
discharge are the same.  
All remaining subjects (i.e., without any inpatient hospitalization) from the study 
cohort are included in the non-hospitalization subgroup. 
Step 3. Create the analytic sample for hospitalization prediction 
To create the analytic sample for hospitalization prediction, this study uses a 
nested-case-control study design to construct the sample. In a nested case-control 
study, the number of controls are paired with each case by risk factors. While the 
cases are selected out from the hospitalization subgroup, the controls are selected 
out from the non-hospitalization subgroup.  
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The study cases are excluded if they were hospitalized in the pre-observational 
period from Jan.1, 2010 to Dec.31, 2010. The cases are paired with the controls 
at the ratio 1:1 by gender and age in a range with +/- 5 years of age. For example, 
a male case who is 45 years of age can be paired with two male controls from the 
eligible control group, both of whom are 40 and 50 years of age. 
Step 4. Create the analytic sample for rehospitalization prediction 
To create an analytic sample for rehospitalization prediction, a prospective cohort 
design is applied. At the beginning of the study period, patients from the 
hospitalization cohort are opted in, and then followed up until the end of 
Rehospitalization period to clarify if they acquired a rehospitalization. A qualified 
rehospitalization is a sequentially qualified hospitalization (i.e., admission date is 
different from discharge date). Based on the readmission dates, a patient may 
have multiple qualified rehospitalizations but the study focuses only on predicting 
the initial rehospitalization.  
Patients were excluded if: 
 Encounters indicate that the patients use inpatient service but dates of 
readmission and discharge are the same. 
 The consecutive encounter is a rehabilitation, chemotherapy, radiation 
therapy, psychiatry encounter, or giving birth/delivery because such 
encounters either are pre-scheduled or inevitable. 
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4.2. Outcome measures 
4.2.1. Risk of hospitalization 
In literature, the risk of hospitalization can be measured as hospitalization rate or 
probability of hospitalization. For example, hospitalization rates were calculated by 
1,000 resident days in nursing home. Using this metric allows comparing the rates 
to those reported elsewhere. In addition to the type of measure for the risk of 
hospitalization, some studies used a “short-stay” measure and a “long-stay” 
measure. Since the hospitalization patterns of short and long stayers are 
significantly different, the measure for hospitalization is varied for these two kinds 
of patients. For example, short-stay patients move in a nursing home after a 
hospitalization and probably need short-term care before coming back the 
community. In contrast, long-stay patients require extended chronic care, thus they 
typically do not return to the community.  
In this study, hospitalization is defined as initial admission for all-cause diagnosis 
occurring during the hospitalization period. For each patient, the qualified 
hospitalization is marked as “True”, “False” otherwise. The risk of hospitalization is 
estimated by the probability of hospitalization and is reported at a value between 
0 and 1. The following formula identifies the calculation for the probability of 
hospitalization: 
 (  / ) =
1
 
 ( (  / )
   
   
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 P (HL/X) is probability of occurring hospitalization event for observation X; T is 
total number of t trees in RF; HL is abbreviated for “Hospitalization” 
4.2.2. Risk of rehospitalization  
One of the main difficulties that makes the study of hospital readmission 
controversial is that there is no consensus on how to define an “unplanned” 
readmission (e.g., soon after the time of discharge) that might be prevented by 
implementing better transition care. Different methods consider distinct outcomes 
that results in different readmission rates. Two common approaches are:  
• Method is designed to identify planned hospitalizations. For example, the CMS 
method uses the 30-day unplanned readmission rate (CMS, 2017). 
• Method is used to detect readmissions from all index hospitalizations, such as 
3MTM Health Information System Division Potentially Preventable Readmission 
(HISPPR) measure. The 3MTM HISPPR takes specific index stays and uses 
unplanned all-cause readmission rate as the primary outcome by removing all non-
acute readmissions as well as readmissions for maintenance chemotherapy.  
Mull et al., (2015) conducted a study comparing the 3MTM HISPPR with the CMS 
approach to examine what impacted on hospital profiling in the Veterans Health 
Administration (Mull et al., 2015). The study showed both method had moderate 
correlations in readmission rates for each disease condition (e.g., myocardial 
infarction, heart failure, and pneumonia) and uncertainty over which one was 
superior in assessing hospital performance.  
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This study will apply the 3MTM HISPPR approach to identify each qualified 
rehospitalization event to incorporate into the predictive model for 
rehospitalization. Rehospitalization is defined as subsequent hospitalization 
occurring after the first discharge during the rehospitalization period from Jan. 1, 
2010 to Dec. 31, 2013. The only initial rehospitalization from the index hospital 
discharge is flagged as the study outcome. If no subsequent hospitalization is 
occurred within the time window after the initial hospitalization, the patient is 
considered as having non-rehospitalization. If observed time for a patient after the 
first discharge date is shorter than the time window, the patient is excluded.  
Probability of rehospitalization is reported at a value between 0 and 1: 
 (    / ) =
1
 
 ( (    / )
   
   
 
P (ReHL/X) is probability of occurring rehospitalization for observation X; T 
is total number of t trees in RF; ReHL is abbreviated for “Rehospitalization” 
4.3. Measure of risk factors 
Risk factors for hospitalization or rehospitalization from literature review are 
created from data elements using diagnosis codes, procedure codes, medication 
histories, health status indicators, and health care services utilization. 
4.3.1. Risk factors for hospitalization 
The study hypothesized that a combination of two or more variables associated 
with patient demographics, health care utilization, which includes use of 
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medication, and health status predicts risk of all-cause hospitalizations for COPD 
patients.  For measures of variable importance in Random Forest method used for 
statistical analysis in this study, Strobl et al. (2007) found that these measures 
could be biased if both categorical and continuous predictor variables exist or the 
levels of categorical variables differ substantially (Strobl, Boulesteix, Zeileis, & 
Hothorn, 2007). To avoid the concern, this study uses variables in a categorical 
form with only minor differences in the number of categories per variable.  
 Available demographic factors in this study are age and gender extracted out from 
the enrollment file. Age is identified as an integer from the date of birth to the 
beginning of the pre-observational period (i.e., Jan. 1, 2011) from the enrollment 
file. Then the variable is categorized into two groups from 18 to 50 years of age 
and over 50 years of age.  
Risk factors related to health utilization and health status for hospitalization are 
measured using a two-step process: 
 Step1: Determine the admission date for the hospitalization event, and then 
use it as an index date for both case and control to identify the risk factors 
before the index hospitalization. 
 Step2: Establish a period of 180 days from the identified index date to 
measure the presence of risk factors.  
Risk factors related to health utilization are number of prescriptions, proportion of 
days covered by COPD related drugs, status of antibiotic prescription, status of 
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cardiovascular drug prescription, status of antidepressant prescription, status of 
hypnotic and antipsychotic prescription, status of prescription for other chronic 
diseases, emergency visits, homecare visits, outpatient visits, care management 
use, vaccinated status. Risk factors related to health status are Charlson 
comorbidity index scores and smoking history. The details for names, descriptions, 
and type of the risk factors associated with hospitalization prediction are described 
in Table 3. 
Term Variable Name Operationalization 
and Descriptions 
Type 
Risk of 
hospitalization  
 
HL Initial hospital 
admission for all-cause 
diagnosis occurred 
during the hospitalized 
period   
The admitted date 
requires to be different 
from the discharge 
date 
POS code = 21 
 
Binary variable 
HL = True 
Non-HL = False 
 
 
Age age Age is identified from 
the date of birth to the 
beginning of the pre-
observational period 
(i.e., Jan. 1st, 2011)  
Categorical variable 
18 ≤ age < 50 = 1 
age ≥ 50 = 2 
 
 
Gender gender Gender is identified 
from the enrollment file 
Categorical variable 
Male = 0 
Female = 1 
 
Smoking history smoker Defined as occurrence 
of claims indicating 
smoking (ICD-9-CM 
code 305.1,989.84, 
V15.82,649.0-649.1) 
Categorical  
Smoker = 1 
Non-smoker = 0 
67 
 
Proportion of 
days covered 
by COPD drugs 
copdRxpdc 
 
The ratio of the number 
of days with at least 
one retail refill to the 
total number of 
calendar days following 
(and including) 
medication initiation 
during a determined 
period.  
Accounted for 
overlapping days 
supply (Scott, 2007)  
COPD drugs are 
determined by drug 
groups of specific 
COPD (GPI code 43-
44x), respiratory (GPI 
code 44x, 9710x), and 
corticosteroid (GPI 
code 22x) 
Categorical  
0 % of copdRxpdc = 0 
0 % < copdRxpdc < 80 % = 1 
copdRxpdc ≥ 80 % = 2 
 
Antibiotic 
prescription 
status 
antibioticRx Identified as 
occurrence of claims 
with codes for antibiotic 
groups (GPI code 01-
05x, 16x) 
Categorical  
antibioticRx = 1 
Non-antibioticRx = 0 
Antidepressant 
prescription 
status 
antidepressantRx Identified as 
occurrence of claims 
with codes for 
antidepressants (GPI 
code 58x) 
Categorical  
antidepressantRx = 1 
Non-antidepressantRx = 0 
Cardiovascular 
prescription 
status 
cardiovascularRx Identified as 
occurrence of claims 
with the following 
groups of 
antihypertensive (GPI 
code 33x, 36x, 40x), 
antihyperlipidemic (GPI 
code 39x), other 
cardiovascular (GPI 
code 31- 36x, 83 - 85x) 
Categorical  
cardiovascularRx = 1 
Non-cardiovascularRx = 0 
 
Anxiolytic 
prescription 
status 
anxiolyticRx Identified as 
occurrence of claims 
with the following 
groups of antipsychotic 
(GPI code 59x), 
anxiolytic (GPI code 
57x), 
Categorical  
anxiolyticRx = 1 
Non- anxiolyticRx = 0 
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sensation/hypnotic 
(GPI code 60x) 
Other chronic 
medication 
prescription 
status 
otherChronicRx Identified as 
occurrence of claims 
with the following 
groups of 
hypoglycemic (insulin 
or oral)/ diabetic needs 
(GPI code 27x, 9410x, 
9705x, 9720x) and 
other chronic 
medications (GPI code 
28-30x, 68-69x, 72-
73x, 75x) 
Categorical  
otherChronicRx = 1 
Non-otherChronicRx = 0  
Emergency visit ER Identified as 
occurrence of claims 
with POS code 23 for 
emergency room 
hospital 
Categorical  
ER = 1 
Non-ER = 0 
 
Homecare visit  homecareVS Identified as 
occurrence of claims 
with POS code 12 for 
patient’s home 
Categorical  
homecareVS = 1 
non-homecare = 1 
Number of 
prescriptions 
Rxcount Counted number of 
encounters for each 
patient unique 
identification 
Categorical  
0 claim of Rxcount = 0 
1 ≤ Rxcount < 10 claims = 1 
Rxcount ≥ 10 claims = 2 
 
Outpatient visit outpatientVS Identified as 
occurrence of claims 
with POS code 22 for 
outpatient hospital 
Categorical  
0 visit of outpatientVS = 0 
1 ≤ outpatientVS < 3 times = 1 
outpatientVs ≥ 3 = 2 
Care 
management  
careManage See Appendix 2 for 
careManage 
identification 
Categorical 
careManage = 1 
Non-careManage = 0 
Charlson index 
scores 
charlsonIndex See Appendix 2 for 
charlsonIndex 
identification 
Categorical 
charlsonIndex equals 1 = 1 
1 < charlsonIndex ≤ 3 = 2 
charlsonIndex > 3 = 3 
 
 
Table 3. Risk factors for all-cause hospitalization for COPD patients 
 ICD – 9 – CM: International Classification of Diseases, Ninth   
Revision, Clinical Modification; GPI: Generic Product Identifier for 
medications 
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4.3.2. Risk factors for rehospitalization 
The second hypothesis of the study proposes that a combination of two or more 
variables related to patient demographics (i.e., age and gender), health utilization 
(i.e., number of prescriptions, proportion of days covered by COPD related drugs, 
status of antibiotic prescription, status of cardiovascular drug prescription, status 
of antidepressant prescription, status of hypnotic and antipsychotic prescription, 
status of prescription for other chronic diseases, emergency visits, homecare 
visits, outpatient visits, care management use, vaccinated status, length of stay), 
and health status (i.e., Charlson comorbidity index and smoking history) predicts 
risk of rehospitalizations for COPD patients. Practically, the risk factors of 
rehospitalizations should address two different episodes of the care management 
programs, pre-discharge and post-discharge care management. The study results 
can be useful for identifing high-risk factors to create the pre-discharge care 
management (e.g., Patient education and medical counseling) and post-discharge 
care management (e.g., Follow-up calls and planned outpatient visits).  
For the pre-discharge episode, this study includes factors regarding to health 
utilization during the initial index hospitalization (i.e., number of prescriptions, 
status of COPD prescription, status of antibiotic prescription, status of 
cardiovascular drug prescription, care management use, length of hospital stay of 
index hospitalization). The pre-discharge factors are measured from the admission 
date to the discharge date. 
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For the post-discharge episode, this study consists of factors regarding to health 
utilization after the initial index hospitalization (i.e., number of prescriptions, 
proportion of days covered by COPD related drugs, status of antibiotic prescription, 
status of cardiovascular drug prescription, status of antidepressant prescription, 
status of hypnotic and antipsychotic prescription, status of prescription for other 
chronic diseases, care management use, emergency visit, homecare visit, 
outpatient visit). The post-discharge factors are measured from the discharge date 
to the end of the follow-up (i.e., the readmission date or the end of the 
rehospitalization period).  
Table 4 shows further details of names, descriptions, and type for the risk factors 
associated with the rehospitalization prediction. 
Term Variable 
Name 
Operationalization 
and Descriptions 
Type 
Risk of 
Rehospitalization  
 
 
ReHL The first following 
hospitalization for all-
cause diagnosis 
occurred for the 
same subject after 
the initial 
hospitalization.  
The readmission date 
requires to be 
different from the 
discharge date 
POS code = 21 
 
Binary variable 
ReHL = True 
Non-ReHL = False 
 
Age age Age is identified from 
the date of birth to 
the beginning of the 
pre-observational 
period (i.e., Jan. 1st, 
2011)  
Categorical variable 
18 ≤ age < 50 = 1 
age ≥ 50 = 2 
 
 
Gender gender Gender is identified 
from the enrollment 
file 
Categorical variable 
Male= 0 
Female= 1 
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smoking history smoker Defined as 
occurrence of claims 
indicating smoking 
(ICD-9-CM code 
305.1, 989.84, 
V15.82, 649.0-649.1) 
Categorical 
Smoker = 1 
Non-smoker = 0 
Pre-Discharge Risk Factors 
Pre-discharge risk 
factors 
 Identified during 
hospital time from the 
index admitted date 
to discharge date  
 
COPD 
prescription status 
Pre-copdRx Identified as 
occurrence of claims 
with codes for drug 
groups of specific 
COPD (GPI code 43-
44x), respiratory (GPI 
code 44x, 9710x), 
and corticosteroid 
(GPI code 22x) 
Categorical 
Pre-copdRx = 1 
Non-Pre-copdRx = 0 
Antibiotic 
prescription status  
Pre-
antibioticRx 
Identified as 
occurrence of claims 
with codes for 
antibiotic groups (GPI 
code 01-05x, 16x) 
Categorical  
Pre-antibioticRx = 1 
Non-Pre-antibioticRx = 0 
Cardiovascular 
prescription status 
Pre-
cardiovascula
rRX 
Identified as 
occurrence of claims 
with following groups 
of antihypertensive 
(GPI code 33x, 36x, 
40x), 
antihyperlipidemic 
(GPI code 39x), other 
cardiovascular (GPI 
code 31- 36x, 83 - 
85x) 
Categorical  
Pre-cardiovascularRx = 1 
Non-Pre-cardiovascularRx = 0 
 
Care 
Management 
Pre-
careManage 
See Appendix 1 Categorical 
Pre-careManage = 1 
Non-Pre-careManage = 0 
Number of 
prescription 
Pre-Rxcount Counted number of 
encounters for each 
patient unique 
identification 
Categorical 
Pre-Rxcount with 0 claim = 0 
1 ≤ Pre-Rxcount < 3 claims = 1 
Pre-Rxcount ≥ 3 claims = 2 
 
Length of stay in 
hospital 
length.of.stay Length of stay is 
identified as 
difference between 
the admitted date and 
the discharge date 
Categorical 
 length.of.stay equals 1 = 1 
1 < length.of.stay < 5 = 2 
length.of.stay ≥ 5 = 3 
 
Post-Discharge Risk Factors 
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Post-discharge 
risk factors 
 Identified from the 
post-discharge date 
to the readmission 
date  
 
Proportion of days 
covered by COPD 
drugs during post-
discharge 
Post-
copdRxpdc 
 
Like 
operationalization of 
copdRxpdc for HL 
prediction except the 
time interval is 
different 
Categorical  
0 % of Post-copdRxpdc = 0 
0 % < Post-copdRxpdc < 80 % = 
1 
Post-copdRxpdc over 80 %= 2 
 
Anxiolytic-related 
prescription status 
during post-
discharge 
Post-
anxiolyticRx 
Identified as 
occurrence of claims 
with following groups 
of antipsychotic (GPI 
code 59x), anxiolytic 
(GPI code 57x), 
sensation/hypnotic 
(GPI code 60x) 
Categorical  
Post-anxiolyticRx = 1 
Non-Post-anxiolyticRx = 0 
Antibiotics-related 
prescription status 
during post-
discharge 
Post-
antibioticRx 
Identified as 
occurrence of claims 
with codes for 
antibiotic groups (GPI 
code 01-05x, 16x) 
Categorical  
Post-antibioticRx = 1 
Non-Post-antibioticRx = 0 
Antidepressant-
related 
prescription status 
during post-
discharge 
Post-
antidepressa
ntRx 
Identified as 
occurrence of claims 
with codes for 
antidepressants (GPI 
code 58x) 
Categorical  
Post-antidepressantRx = 1 
Non-Post-antidepressantRx = 0 
Cardiovascular-
related 
prescription status 
during post-
discharge 
Post-
cardiovascula
rRx 
Identified as 
occurrence of claims 
with following groups 
of antihypertensive 
(GPI code 33x, 36x, 
40x), 
antihyperlipidemic 
(GPI code 39x), other 
cardiovascular (GPI 
code 31- 36x, 83 - 
85x) 
Categorical  
Post-cardiovascularRx = 1 
Non-Post- cardiovascularRx = 0 
 
Other chronic 
medication-
related 
prescription status 
during post-
discharge 
Post-
otherChronic
Rx 
Identified as one or 
more occurrences of 
claims with following 
groups of 
hypoglycemic (insulin 
or oral)/ diabetic 
needs (GPI code 27x, 
9410x, 9705x, 9720x) 
and other chronic 
medications (GPI 
code 28-30x, 68-69x, 
72-73x, 75x) 
Categorical  
Post-otherChronicRx = 1 
Non-Post-otherChronicRx = 0  
Emergency visit 
during post-
discharge 
ER Identified as 
occurrence of claims 
with POS code 23 for 
Categorical  
ER = 1 
Non - ER = 0 
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emergency room 
hospital 
Homecare visit 
during post-
discharge 
homecareVS Identified as 
occurrence of claims 
with POS code 12 for 
patient’s home 
Categorical  
homecareVS = 1 
non - homecare = 1 
Outpatient visit 
during post-
discharge 
outpatientVS Identified as 
occurrence of claims 
with POS code 22 for 
outpatient hospital 
Categorical  
0 vist of outpatientVS = 0 
1 ≤ outpatientVS < 3 times = 1 
outpatientVs ≥ 3 = 2 
Number of 
prescriptions 
during post-
discharge 
Post-Rxcount Counted number of 
prescription 
encounters during a 
determined period  
(from discharge date 
to rehospitalization 
date) in the pharmacy 
claims 
Categorical  
Post-Rxcount ≤ 25 claims = 1 
Post-Rxcount > 25 claims = 2 
 
 
Care 
management  
careManage See Appendix 2 for 
careMange 
identification 
Categorical 
careManage = 1 
Non-careManage = 0 
Charlson index 
scores 
charlsonIndex See Appendix 2 for 
charlsonIndex of 
identification 
Categorical 
charlsonIndex equals 1 = 1 
1 < charlsonIndex ≤ 3 = 2 
charlsonIndex > 3 = 3 
 
   
Table 4. Risk factors of all-cause rehospitalization for COPD patients 
 ICD – 9 – CM: International Classification of Diseases, Ninth 
Revision, Clinical Modification; GPI: Generic Product Identifier for 
medications 
4.4. Random Forests 
4.4.1. K-fold Cross - validation 
The most widely used method for estimating prediction error is cross-validation. 
Since data are often insufficient, it is usually impossible to spare a validation set 
and use it to validate the performance of our prediction model. To address the 
problem of insufficient data, K-fold cross - validation uses part of the available data 
to fit the model, and a different part to test it. The study data is randomly split into 
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equal-sized parts designated as ‘K’. The actual number of K depends on a study’s 
purpose and the training size available (Hastie, Tibshirani, & Jerome, 2009).  
For example, a dataset is randomly split into three Ks. The cross-validation will 
proceed in three iterations as follows:  
Iteration 1: the 1st and 2nd Ks will be training datasets and the third K will serve as 
validation dataset. A statistical model is fit for each training dataset.  
K 1 2 3 
Data set Training Training Validation 
Iteration 2: the process is repeated this time with the 1st and 3rd K identified as the 
training sets and the 2nd K as the validation set.  
K 1 2 3 
Data set Training Validation Training 
Iteration 3: the process is repeated this time with the 2nd and 3rd K identified as the 
training sets and the 1st K as the validation set. 
K 1 2 3 
Data 
set 
Validation Training Training  
The prediction error is then calculated for each training set compared to the 
validation set. The prediction error of the fitted model is averaged across the three 
iterations.  
This study will apply Random Forest model to identify important factors that 
contribute to the HL and ReHL prediction. Random Forest model is built up on two 
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important parameters that are random tree sizes (ntree) and random subset of 
variables (mtry) for splitting node. To select optimal values for ntree and mtry, it is 
important to note that both parameters should be evaluated simultaneously rather 
than selecting one at a time or using default values as previous studies applied the 
Random Forest technique (Ward, Pajevic, Dreyfuss, & Malley, 2006b), 
(Parvathaneni, Hester, Cheriyath, & Fischman, 2012). For this study, the K-fold 
cross-validation served as a procedure of internal validation will be programed in 
R to test multiple combinations of ntree and mtry. The combination that gives the 
lowest prediction errors will be the best option for ntree and mtry.  
For instance, ntree and mtry create n combinations. Each combination will give a 
prediction error regarding to each training set of the K-fold cross-validation. The 
average prediction error for each combination will be calculated as the following 
Table 5.  
Model K1 K2 K3 The average prediction errors 
The 1st combination of 
model parameters 
E11 E12 E13 (E11 + E12 + E13)/3 
The 2nd combination 
of model parameters 
E21 E22 E23 (E21 + E22 + E23)/3 
The 3rd combination 
of model parameters 
E 31 E32 E33 (E31 + E32 + E 33)/3 
The nth combination 
of model parameters 
En1 En2 En3 (En1 + En2 + En3)/n 
 
Table 5. Averaging prediction errors from K-fold cross-validation method 
Then, the average prediction error will compare each other to choose the one with 
the lowest prediction error. 
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4.4.2. Bootstrap method 
Bootstrap is a general tool for assessing statistical accuracy. For example, we 
have a model fit to a set of training data with observations (N). Typically, we will 
randomly draw datasets with replacement from the training data. Each sample has 
the same size as the original training set. This is generated times (B) producing B 
bootstrap datasets, as shown in Figure 17.  
Bootstrap is one of techniques applied in the Random Forest method. 
Theoretically, after bootstrapping, there always are approximate 1/3 of number of 
observations from the training data not included in the bootstrap data set serving 
as a new dataset to validate the fitted model, so-called an internal validation. In 
Random Forest, the new dataset is called “Out-of-Bag sample”. The Out-of-Bag 
(OOB) samples are refitted to the models and examine the behavior of the fits over 
the OOB samples. 
Training data 
    N 
               
     Figure 17. Bootstrapping process for a data set with N observations 
B Bootstrap dataset 
    N 
       N 
    N 
 
Out of Bag samples 
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4.4.3. The Random Forests Algorithm 
Random forests (RF) is a machine learning classifier. First, RF is built by many 
decision trees using a training set and a testing set, and then trees are combined 
into one single prediction. Each of the aggregated decision trees is built separately 
on a bootstrapped random sample taken with replacement from the training data. 
Each of the decision trees uses randomly selected subset of predictors for splitting 
tree node. Thus, randomness appears twice in the process of RF.  
In summary, the Random Forests algorithm is as following steps: 
1. Data division: Divide the analytic sample into two parts, a training set and 
test set 
2. Sampling with replacement: Draw bootstrap samples from the training data  
3. Random forests of trained trees: Grow a classification tree for each of the 
bootstrapping sample by using a random subset of predictors  
4. Prediction: Predict test data by the Random Forests 
5. Final Prediction: Aggregate the predictions of the Random Forest 
Literature indicated that traditional classifier models might be biased towards 
majority class that produces poor prediction accuracy over the minority class for 
an unbalanced dataset. However, the most commonly used classification 
algorithms do not work well for such problems because they aim to minimize the 
overall error rate, rather than paying special attention to the minority class. Like 
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most current classifiers, RF is suffered from an extremely imbalanced training data 
set. As it is constructed to minimize the overall error rate, it tends to focus more on 
the prediction accuracy of the majority class, which often results in poor accuracy 
for the minority class. In this study, this study will examine whether the training set 
is substantially unbalanced before building models.  
We consider a so-called substantial unbalanced dataset if binary dependent 
variables have less than 20 % for the minority class.  If the issue of unbalance is 
occurred, the balancing techniques are required to apply for addressing it. 
Package ‘randomForest’ in R software (L. Breiman & Cutler, 2015) is used to 
develop models for this study. 
OOB error from the fitted model can be used to estimate the generalization error 
for the based model. To calculate the OOB error, after each tree is built, the 
observations that are not included in the bootstrap samples will be used as a 
testing data for this tree and the error rate is calculated. As adding each additional 
tree into the forest, the value of the OOB error rate is averaged over all the trees. 
From Figure 18, the value of the OOB error decreases with increasing numbers of 
built trees in the training. Flattened part of the curve indicates that the number of 
built trees is high enough, which indicate that there is no further increase of 
accuracy with growing number of built trees. The black curve represents the overall 
error, while the green and red curves represent the error connected with prediction 
of the value of the outcome (“True” and “False” respectively). In addition, a stable 
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linear line with low OOB error can indicate adaptability of the fitted models with the 
data set that means the used parameters for the models are appropriate. 
 
Figure 18. Out of bag error 
4.4.4. Variable importance 
RF model can generate information on importance of the predictors in the model. 
There are three common measures of predictor importance used by RF:  
 Counting the number of times each predictor selected by all trees: The more 
counts predictor has, the more important predictor is.  
 Mean Decrease Accuracy (MDA): If a predictor is associated with the 
outcome, the original association will be lost after permuting the predictor. 
To assess the importance of the predictors for the model, each predictor is 
went down the tree and prediction is calculated. Then, the values of the 
predictor are randomly permuted in out-of-bag data, while values of all other 
predictors kept. The modified out-of-the bag data are went down the tree 
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and new predictions are computed. Comparing the predictions of the 
original one and the one with permuted variable, the difference of mean 
decrease of accuracy (MDA) is obtained. Predictor with the higher value is 
more important than others. Recently, Breiman (2001) recommended that 
this measure has been dropped because studies showed it was too volatile 
when there were many variables (L. E. O. Breiman, 2001). 
 Mean decrease of Gini: This measure is based on Gini index decrease. Gini 
index is a measure of impurity, where the split of most Gini decrease is 
chosen at each node. In Random Forest, adding up all Gini decreases for 
each individual variable over all trees generates a list of variable 
importance.  
       
 
Gini value is calculated from probability pi of each class i of a variable; i range from 
1 to c classes. For instance, there are two classes for binary case (c=2). 
The following data example illustrates how to calculate the Gini index, how to apply 
a splitting rule   for all trees, and identify important variables.  
Patient ID Hospitalization ER visit Homecare visit 
1 True yes yes 
2 False no no 
3 True yes no 
4 True no no 
5 False no yes 
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Overall Gini for the dataset = 1 – [(p(true))2 + (p(false))2] = 1 – [(3/5)2 + (2/5)2] = 
0.48 
The definition of the splitting rule states that the variable with the maximum of Gini 
decreased from the overall Gini gives the best purity of target distribution after each 
split. Therefore, to establish the splitting rule for this example, the Gini index for 
each variable is calculated:  
Gini for “yes” ER visit = 1 – [(p(true))2 + (p(false))2] = 1 – [(2/2)2 + (0/2)2] =0 
Gini for “no” ER visit = 1 – [(p(true))2 + (p(false))2] = 1 – [(1/3)2 + (2/3)2] = 0.45 
Gini for “yes” Homecare visit = 1 – [(p(true))2 + (p(false))2] = 1 – [(1/2)2 + (1/2)2] 
=0.5 
Gini for “no” Homecare visit= 1 – [(p(true))2 + (p(false))2] = 1 – [(2/3)2 + (1/3)2] = 
0.44 
Next the variable with the largest Gini decrease is identified: 
Gini split= (n “yes” ER visit/n total) * (Gini for “yes” ER visit) + (n “no” ER visit/n 
total) * (Gini for “no” ER visit) = 2/5 (0) + 3/5(0.45) = 0.27 
Gini decrease for ER visit = 0.48 – 0.27 = 0.21 
Gini split= (n “yes” Homecare visit /n total) * (Gini for “yes” Homecare visit) + (n 
“no” Homecare visit /n total) * (Gini for “no” Homecare visit) = 2/5 (0.5) + 3/5(0.44) 
= 0.46 
Gini decrease for Homecare visit = 0.48 – 0.46 = 0.02 
Finally, following the splitting rule, ER visit is selected as the best splitting variable 
because the Gini decrease for ER visit (i.e., 0.21) is greater than the Gini decrease 
for Homecare visit (i.e., 0.02).  
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In addition, Gini values decreases for all nodes of trees for each variable are 
averaged, and then compared with one another to determine the variable that 
creates a higher mean decrease of Gini. The higher mean decrease of Gini is the 
more important variable for the predictive model. This measure is the most reliable 
measure currently in practice, thus this study will apply the measure (Mean 
decrease of Gini) to evaluate for variable importance. 
4.4.5. Partial Dependence Plot  
Although the predictive importance of a predictor is insightful, another interested 
question is how a predictor is related to the predicted outcome. Partial dependence 
is a method, based on predictions from the Radom Forest, to visualize the partial 
relationship between the outcome and the predictors as detected by the Random 
Forest (Hastie et al., 2009).  
The algorithm of partial dependence for the Random Forest method is following 
these bullet points:  
1. For each interested variable, all observations are given the same 
value on the variable to create a new data set while other variables 
are kept unchanged.  
2. Next, this data set is passed down the forest, and a prediction for 
each observation is obtained.  
3. By averaging over these predictions, a prediction for the created data 
set is obtained. Repeating the step 1,2, and 3 for all values of the 
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variable of interest gives the relationship between the interested 
variable and the outcome over its range.  
4. Visualize the relationship by plotting the variable of interest against 
the average predictions for the created dataset. 
This study will use the package “plotmo” (Milborrow, 2017) in R software to create 
both two-dimensional representing the relationship between the predicted values 
and interested variable averaged across other predictors and three-dimensional 
plots investigating interactions of predictors.  
4.4.6. Prediction 
Once the training phase is accomplished, predictions can be performed for new 
incoming observations from the test dataset by sending them through all trees of 
the forest and combining tree posteriors. A common approach to compute the 
forest prediction Y for an observation X is to average the tree posteriors. For 
example, Figure 19 shows how to estimate three class posteriors of Y each tree in 
random forests. 
 
Figure 19. Class posteriors for each tree  
X 
Y 
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Each tree builds a partition Pt over the risk factors’ space and class 
posteriors can be easily estimated in each cell of Pt. 
 ( / ) =
1
 
 ( ( / ,   )
   
   
 
  Pt is partition induced by T trees; X is observation; Y is prediction outcome 
By using Random Forest models, patients can be ranked regarding to predicted 
probabilities to separate patients into lower and higher risks of hospitalization or 
rehospitalization. That aims to provide more information assisting patient 
education at community or discharge decisions on each patient at hospital.  
4.5. Summary of analysis 
This study will apply the RF method to address the aims of this study. The analysis 
part working with the RF method can be described as 4 following stages (see 
Figure 20) : 
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Figure 20. Outline for summary of analysis 
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Stage 1: Data preparation  
 Divide the analytic sample into two parts, a training set and test set. 
There was no standardization in the Random Forest for dividing the whole data set 
into the training set and the testing set. Previous studies accepted the partition of 
75:25 as a valid ratio for the training set and testing set without a validation 
(Parvathaneni et al., 2012). Thus, this study proposes to use OOB error for 
validating the different partitions (i.e., 55:45, 65:35, 75:25). By using the default 
value for random subset of predictors (i.e., the square root of the number of 
predictors) to build the RF models, OOB errors of the models will be plotted against 
a range of tree sizes from 0 to 2000 trees to detect which option of the partition will 
give the lowest OOB error.  
 Applying K-fold cross-validation to find out the optimal values for number of 
random tree sizes and random subset of predictors.  
To improve the classification performance of the models based on RF, the optimal 
values for two parameters -- the number of trees and the number of subset of the 
predictors – should be detected before fitting predictors into model. The result from 
K-fold cross-validation on the training set will indicate the optimal values for both 
parameters that are expected to give the most accuracy for the fitted models. 
 Bootstrapping to create multiple samples from the training data. 
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Since each tree is constructed using a bootstrap sample, the number of bootstrap 
samples depends on the number of the Random Forest models needed to create 
for the study’s purpose.  
Stage 2. Model training 
The models with the optimal values of the parameters (i.e., ntre and mtry) will be 
participated in the training session. During the training session, the process of 
bootstrapping and building models can be repeated as many as needed for model 
training. For instance, if the RF Base model including 1000 trees, the process is 
repeated 10 times. Each iteration will generate 1000 random RF tree models from 
1000 random bootstrapping samples.  
Stage 3. Model selection 
Validating the fitted models with the testing set to select the final model. The 
following values will be used to evaluate the models: 
 Out-of-bag (OOB) error 
OOB expressed as a percentage of predictive errors using observations not trained 
for each decision tree in the forest and aggregating over all. For example, the OOB 
error value is X %. This suggests that the model has (100-X) % out of sample 
accuracy for the training set. The less the OOB error is, the more accurate the 
model gets. The accuracy is reported between 0 and 1 and the confident interval 
for the accuracy is informed as well.  
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 Classification accuracy = correct predictions / total predictions 
 Comparing the predicted outcome to the observed outcome 
As applied the test set to the fitter models, four different combinations of probability 
of the model detection can be obtained (i.e., True Positive (TP), True Negative 
(TN), False Positive (FP), and False Negative (FN)). The models in this study is 
built to predict Hospitalization/Rehospitalization, i.e. whether the patient is 
hospitalized or not and whether patient is hospitalized/rehospitalized or not within 
the follow-up time.  
 The true positive outcome (TP): Correctly predicted patients being 
hospitalized/rehospitalized. 
 True negative outcome (TN): Correctly predicted patients not being 
hospitalized/rehospitalized. 
 False positive outcome (FP): A patient is predicted to be 
hospitalized/rehospitalized, while not hospitalized/rehospitalized in the 
reality.  
 False negative outcome (FN): A patient is predicted not to be 
hospitalized/rehospitalized, while hospitalized/rehospitaized in the reality. 
The values of TP, TN, FP and FN for each observation in the testing dataset 
provides information to evaluate the predicting ability of the model. In addition to 
these values, sensitivity and specificity can be calculated. Sensitivity (True positive 
89 
 
rate) indicates the ability of the model for identification of positive patterns, i.e. it is 
the proportion of all patients being hospitalized/rehospitalized who were correctly 
identified by the model: 
Sensitivity =
TP
FP + TN
 
Specificity (True negative rate) describes the ability of model to identify negative 
patterns that means proportion of all patients not being hospitalized/rehospitalized, 
who were correctly predicted by the model: 
Specificity =
TN
FP + TN
 
If both Sensitivity and Specificity are high, model have high accuracy. 
 Area under the Receiving Operating Characteristic (AUROC) curve C-
statistics 
The ROC curve is a graphical tool that demonstrates the performance of a 
classifier by plotting sensitivity vs. 1 – specificity. In other words, moving along the 
ROC from bottom-left to top-right trades off false positives for false negatives. For 
example, Hajian-Tilaki (2013) described that  a test with good classification 
performance should be located close to the upper left corner of the diagram, while 
test producing random guesses is located along the diagonal connecting the points 
TRP=0, FPR=0 and TRP=1, FPR=1 (see Figure 5) (Hajian-Tilaki, 2013). In Figure 
5, the performance of test A was better than the performance of test B in the study 
of Hajian-Tilaki (2013). 
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Figure 21. The ROC used to compare test performance  
          Source: (Hajian-Tilaki, 2013)  
Similarly, the area under the ROC curve, so-called AUC or c-statistics, can be 
calculated to assess predictive power of the model. AUC can be defined as the 
proportion of times a given classifier correctly discriminates a random pair of 
patients with and without admission/readmission. If AUC is close to 1, model is 
good at prediction ability, and AUC around 0.5 indicates that model prediction 
ability is only on random. The model with higher value of AUC is better than another 
one. 
 Cohen’s Kappa statistic (K) 
Cohen’s Kapa statistic accounts for the agreement between the model’s 
predictions and true values. Kappa values range from -1 to 1. The maximum value 
of 1 indicates perfect agreement between the model’s predictions and true values.  
K =
po pe
1 pe
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 po is the observed proportional agreement between predictions and true 
values. pe is the probability of chance agreement.  
If there is no agreement among the raters other than what would be expected by 
chance (as given by pe), κ ≤ 0. 
The K value can be interpreted as follows (Altman, 1991) (see Table 6) 
Value of K Strength of agreement 
< 0.20 Poor 
0.21 - 0.40 Fair 
0.41 - 0.60 Moderate 
0.61 - 0.80 Good 
0.81 - 1.00 Very good 
 
         Table 6. Interpretation of Kappa value 
Stage 4. Prediction to classify patients by groups of different risk of 
hospitalization or rehospitalization 
This study will apply the whole dataset to the final model for the HL prediction or 
the ReHL prediction to get the probability of HL/ReHL for individual patients. Then, 
the values of the probabilities will be ranked from low values to high values to 
classify the patients in the whole dataset into three groups: 
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 Low risk (P Hospitalization < 50) 
 Medium risk (50% ≤ P Hospitalization < 80%)  
 High risk (P Hospitalization ≥ 80%)  
For the ReHL prediction, risk of ReHL can be classified into three following groups: 
 Low risk (P Rehospitalization < 50) 
 Medium risk (50% ≤ P Rehospitalization < 80%)  
 High risk (P Rehospitalization ≥ 80%)  
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Chapter 5. RESULTS 
Chapter 5 report our findings for this study. First, Chapter 5 present steps of data 
construction to describe how to create the two analytic samples for the 
hospitalization and rehospitalization prediction. Second, this chapter present 
results of statistical analysis. For each study outcome (i.e., hospitalization and 
rehospitalization), results of statistical analysis are included two parts, including 
descriptive analysis and predictive modeling with Random Forest. The first part is 
findings from descriptive analyses for the analytic samples used for predictive 
modeling. In the second part, this chapter reports results of the Random Forest 
application following stages in the summary of analysis of Chapter 4. These stages 
are included data preparation, model training, model selection, and prediction.    
5.1. Data construction 
Figure 22 shows the patient selection flowchart leading to the definitions of the 
two-study analytic samples for hospitalization and re-hospitalization prediction.  
Step1. Enrollment 
There were 8,085 records of patients in the member file. 7,505 patients were over 
18 years of age. Among them, 3,050 eligible patients continuously enrolled from 
Oct. 1, 2010 to Dec. 31, 2013. Among these continuously enrolled patients, 252 
patients were diagnosed with COPD that created the study cohort.  
Step2. Allocation 
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The study cohort was divided into two subgroups: a subgroup of 82 patients with 
hospitalization and a subgroup of 170 patients without hospitalization. Among 82 
patients with hospitalization, 8 patients were excluded because dates of admission 
and discharge were the same that created the hospitalization subgroup with 74 
patients. 
Step3. Create the analytic sample for hospitalization prediction 
While the cases were randomly selected out from the hospitalized subgroup (i.e., 
74 patients), the controls were selected out from the non-hospitalized subgroup 
(i.e., 170 patients). Nineteen cases were excluded because they had 
hospitalizations in the pre-observational period from Jan. 1, 2010 to Dec. 31, 2010. 
Only one female case who was 72 years of age could not find a control for 
matching. Finally, 54 cases were matched with 54 controls at the ratio 1:1 by 
gender and age in a range with +/- 5 years of age that created the final analytic 
sample for hospitalization prediction with 108 patients in total.  
Step 4. Create the analytic sample for rehospitalization prediction 
Patients from the hospitalization cohort (i.e., 74 patients) were opted in and then 
followed up until the end of the time frame to clarify if they acquired a 
rehospitalization. Only one patient was excluded because of unqualified 
rehospitalization. There was no one excluded by checking the observed time if it 
was shorter than the window time averaged from discharge date to readmission 
date (i.e., 340 days) and examining encounters for inevitable events (e.g., 
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rehabilitation, chemotherapy, radiation therapy, psychiatry encounter). The final 
analytic sample for rehospitalization prediction was included 73 patients. 
 
 
       Figure 22. Flow chart for patient selection 
5.2. Hospitalization prediction 
5.2.1. Descriptive analysis 
The characteristics of 108 patients from the final analytic sample for hospital 
prediction were summarized in Table 7. Forty-six patients (42.6 %) were female, 
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seventy-four patients (68.5 %) were over 50 years of age, and forty-two patients 
(38.9 %) had smoking. The follow-up time for identifying the patient characteristics 
was 180 days from the identified index date described in Chapter 4. 
Patient Characteristics 
   
  n                                   
  Hospitalization = True (%)     
  gender = 1 (%)               
  age = 2 (%)                  
  smoker = 1 (%)               
  Rxcount (%)                            
     0                         
     1                         
     2                         
  copdRxpdc (%)                          
     0                         
     1                         
     2                         
  antibioticRx = 1 (%)         
  cardiovascularRx = 1 (%)     
  antidepressantRx = 1 (%)     
  otherRx = 1 (%)              
  anxiolyticRx = 1 (%)         
  homecareVS = 1 (%)            
  ER = 1 (%)                   
  outpatientVS (%)                       
     0                         
     1                         
     2                         
  charlsonIndex (%)                      
     1                         
     2                         
     3                          
  careManage = 1 (%)           
   
 
 
108 
54 (50.0) 
46 (42.6) 
74 (68.5) 
42 (38.9) 
 
14 (13.0) 
52 (48.1) 
42 (38.9) 
 
69 (63.9) 
19 (17.6) 
20 (18.5) 
53 (49.1) 
46 (42.6) 
31 (28.7) 
34 (31.5) 
17 (15.7) 
16 (14.8) 
25 (23.1) 
 
37 (34.3) 
38 (35.2) 
33 (30.6) 
 
53 (49.1) 
50 (49.1) 
  5 (  4.3) 
29 (26.9) 
 
Table 7. Patient characteristics of the analytic sample for hospitalization 
prediction  
Table 8 showed the characteristics stratified by Hospitalization. Chi-square 
independence tests were used for all categorical variables to show differences 
between the patients hospitalized and the patients not hospitalized. Fisher’s exact 
tests were applied instead of chi-square tests when less than 80 % of the cells 
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show frequencies > 5. There were only three variales (i.e., OutpatientVS, 
charlsonIndex, and careManage) showed significant associations with 
hospitalization. In the HL group, twenty-three patients (42.6 %) were female, thirty-
seven patients (68.5 %) were over 50 years of age, and twenty-three patients (42.6 
%) had smoking. In the nonHL group, twenty-three patients (42.6 %) were female, 
thirty-seven patients (68.5 %) were over 50 years of age, and nineteen patients 
(35.2 %) had smoking. 
Patient characteristics  Hospitalization non-Hospitalization P 
n 
gender = 1 
age = 1 
smoker = 1 
Rxcount (%) 
0 
1 
2 
copdRxpdc (%) 
0 
1 
2 
antibioticRx = 1 (%) 
cardiovascularRx = 1 (%) 
antidepressionRx 
otherChronicRx = 1 (%) 
anxiolyticRx = 1 (%) 
homecareVS = 1 (%) 
careManage = 1 (%) 
ER = 1 (%) 
outpatientVS (%) 
0 
1 
2 
charlsonIndex (%) 
1 
2 
3 
54 
23 (42.6) 
37 (68.5) 
23 (42.6) 
 
 5 (  9.3) 
23 (42.6) 
26 (48.1) 
 
36 (66.7) 
  8 (14.8) 
10 (18.5) 
29 (53.7) 
27 (50.0) 
18 (33.3) 
22 (40.7) 
  7 (13.0) 
11 (20.4) 
25 (46.3) 
15 (27.8) 
 
12 (22.2) 
17 (31.5) 
25 (46.3) 
 
12 (22.2) 
37 (68.5) 
  5 (  9.3) 
54 
23 (42.6) 
37 (68.5) 
19 (35.2) 
 
 9 (16.7) 
29 (53.7) 
16 (29.6) 
 
33 (61.1) 
11 (20.4) 
10 (18.5) 
24 (44.4) 
19 (35.2) 
13 (24.1) 
12 (22.2) 
10 (18.5) 
  5 (  9.3) 
 4 (  7.4) 
10 (18.5) 
 
25 (46.3) 
21 (38.9) 
  8 (14.8) 
 
41 (75.9) 
13 (24.1) 
  0 (  0.0) 
 
 
1.000 
1.000 
0.554 
0.121 
 
 
 
0.739 
 
 
 
0.441 
0.173 
0.395 
0.062 
0.597 
0.176 
<0.001* 
0.361 
 0.001* 
 
 
 
<0.001* 
 
 
(*) for significant P value at 0.001 
  Table 8. Patient characteristics stratified by Hospitalization  
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5.2.2. Random Forest for hospitalization prediction 
Data preparation 
 Data division 
The entire data set available for the modeling was randomly divided into two parts, 
so-called the training set and the testing set. This study investigated three different 
rates of the data division that were 55 %, 65 %, or 75 % of the analytic sample 
using for the training sets. To assess the different rates, RF model with 2000 trees 
and splitting nodes using three predictor variables (i.e., the default value of RF 
model for the dataset with 15 variables) was built on the training sets. The results 
of out of bag errors (OOB) which represented estimate of misclassification rates 
for RF model suggested adaptive ability of RF model on the training set, thus, it 
implied an appropriate rate for the data division. Table 9 presented OOB values 
and misclassification rates for HL and nonHL at different rates of the data division.  
 
Estimate of  
misclassification rate 
 
55 % of the data  
for the training 
set 
 
65 % of the data  
for the training set 
 
75 % of the 
data  
for the 
training set 
 
Out of bag error (SD*) 
 
33.4 (2.3) 
 
30.3 (1.4) 
 
25.5 (1.2) 
 
 
Misclassification for HL (SD*) 
 
28.0 (2.8) 
 
23.6 (1.9) 
 
26.2 (1.4) 
 
 
Misclassification for nonHL (SD*) 
 
38.9 (2.7) 
 
37.7 (2.2) 
 
24.8 (1.5) 
 
 *SD: Standardization 
  
 
Table 9. Estimate of misclassification for 2000 trees for hospitalization prediction 
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At the rate 75 % for the training set, it indicated the RF model on the training set 
outperformed RF model built on the training sets from 55 % or 65 % of the entire 
data. The rate 75 % for the training set showed the lowest OOB error (i.e., 25.5 %) 
in comparison with the rate 55 % or 65 % for the training set (i.e., 33.4% and 
30.3%). 
 
 
 
                                          (a)  (b) 
          Figure 23.  OOB of three different ratios of the data division 
                OOB1: 55 % of data for training 
                   OOB2: 65 % of data for training  
                                        OOB3: 75 % of data for training 
In addition, the plots in Figure 23 (a) and boxplots in the Figure 23 (b) 
demonstrated the RF model including from 1 tree to 2000 trees built on the training 
set sampling from 75 % of the data (i.e., blue color) had consistently lower OOB 
than the RF model built on the training sets sampling from 55 % (i.e., red color) or 
65 % (i.e., green color) the entire data set.  
100 
 
With 75% of the data for training and 25 % of the data for testing, the training set 
consisted 81 patients, out of which 42 patients (i.e., 51.0 %) were hospitalized; the 
testing set consisted 27 patients, with 12 patients (i.e.,44.4 %) were hospitalized. 
Since the training set was not serious imbalance between HLs and non-HLs, it was 
not required to balance the dataset to avoid prioritizing of any of the predicted 
outcomes. The characteristics of patients in the training set and testing set were 
presented in Table 10. 
Patient characteristics    Training Set 
    N = 81 
Testing set 
     N = 27 
   
  Hospitalization = True (%)   
  gender = 1 (%)                    
  smoker = 1 (%)                   
  age = 2 (%)                 
  Rxcount (%)                           
     0                        
     1                        
     2                         
  copdRxpdc (%)                         
     0                        
     1                        
     2                         
  antibioticRx = 1 (%)        
  cardiovascularRx = 1 (%)     
  antidepressantRx = 1 (%)    
  otherChronicRx = 1 (%)       
  anxiolyticRx = 1 (%)        
  homecareVS = 1 (%)            
  ER = 1 (%)                   
  outpatientVS (%)                      
     0                         
     1                          
     2                         
  charlsonIndex (%)                     
     1                          
     2                         
     3                          
  careManage = 1 (%)          
   
 
42 (51.0) 
34 (42.0) 
32 (39.5) 
56 (69.1) 
 
13 (16.0) 
38 (46.9) 
38 (46.9) 
 
51 (63.0) 
14 (17.3) 
16 (19.8) 
40 (49.4) 
32 (39.5) 
22 (27.2) 
29 (35.8) 
14 (17.3) 
10 (12.3) 
19 (23.5) 
29 (35.8) 
25 (30.9) 
27 (33.3) 
36 (44.4) 
40 (49.4) 
  5 (  6.2) 
 22 (27.2) 
 
12 (44.4) 
12 (44.4) 
10 (37.0) 
18 (66.7) 
 
 1 ( 3.7) 
14 (51.9) 
12 (44.4) 
 
18 (66.7) 
  5 (18.5) 
  4 (14.8) 
13 (48.1) 
14 (51.9) 
  9 (33.3) 
  5 (18.5) 
  3 (11.1) 
  6 (22.2) 
  6 (22.2) 
 
  8 (29.6) 
13 (48.1) 
  6 (22.2) 
 
17 (63.0) 
10 (37.0) 
  0 (  0.0) 
  7 (25.9) 
 
Table 10. Patient characteristics for hospitalization prediction in the 
training and testing set  
101 
 
 Finding optimal trees and a subset of random variables for splitting 
node choices by K-fold cross-validation 
A 3-fold cross-validation was applied to internally validate appropriate number of 
trees (ntree) and number of random variables (mtry) for splitting node choices that 
were used to build RF models on the training set. The 3-fold cross-validation 
process was implemented as following steps: 
 The training set was randomly divided into 3 parts. Each part consisted 27 
patients. Two parts served as two new training sets while the remaining part 
served as a new testing set.  
 RF models for each option of tree sizes from 500 to 2000 trees and random 
variables for splitting nodes from two to fifteen variables were built on the 
new training sets, then, cross-validated by the new testing set. 
 Accuracy of model prediction was used to select the optimal model using 
the largest value of accuracy.   
 The cross-validation was repeated three times.  
The results of model accuracy across the tree sizes and random variables for 
splitting node choices were presented in Figure 24. Figure 24 showed the values 
of accuracy through the cross-validation repeated 3 times. The RF model with 
1000 trees (i.e., green line) showed the maximum of accuracy as each splitting 
node randomly chosen from two variables. Thus, the RF model with 1000 trees 
and the splitting nodes using two random variables was expected as the optimal 
model for HL prediction. 
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Figure 24. 3-fold cross-validation across ntree and mtry hospitalization 
prediction 
                         ntree: number of trees for each RF model 
                        mtry: random variables for each subset 
Model training with bootstrapping samples 
The RF model 1000 trees and using two random variables for the splitting node 
choices was called “RF Base Model”. The RF Base model was created from 1000 
trees built up on 1000 bootstrapping samples from the training set. By 10 times of 
iteration, there were 10,000 trees built and trained for the RF Base model. Table 
11 presented the estimates of errors for the RF Base model at each iteration. The 
overall misclassification rates for the RF Base model were averaged from 10,000 
RF trees of 10 iterations. The OOB errors for the RF Base model were 30.2 % and 
misclassification rates for HL, nonHL were 29.8 % and 30.7 % respectively. 
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   iteration 
Error 
1 2 3 4 5 6 7 8 9 10 
OOB (SD*)  28.2 
(2.0) 
28.2 
(2.8) 
31.6 
(2.3) 
30.8 
(3.9) 
31.3 
(1.8) 
27.1 
(3.3) 
31.7 
(2.4) 
27.4 
(1.9) 
32.0 
(1.4) 
34.1 
(1.5) 
Misclassification  
for HL (SD*) 
31.6 
(1.6) 
28.2 
(3.0) 
29.2 
(3.1) 
32.9 
(2.7) 
28.9 
(2.6) 
28.4 
(3.7) 
30.3 
(3.5) 
27.4 
(2.1) 
29.7 
(2.9) 
30.9 
(1.9) 
Misclassification  
for nonHL (SD*) 
24.6 
(3.3) 
28.3 
(3.5) 
34.1 
(3.1) 
28.5 
(6.7) 
33.8 
(4.1) 
25.6 
(3.8) 
33.1 
(2.9) 
27.4 
(2.9) 
34.4 
(3.8) 
37.6 
(2.2) 
 
Table 11. Estimate of errors at each iteration of the Base RF model in training 
    *SD: Standard deviation  
Variable importance for the hospitalization prediction 
To assess the importance of the predictor variables in the RF Base model for the 
HL prediction, the RF Base model generated an important variable list by using the 
Gini measure, which described the mean decrease of Gini index (MDG) for each 
variable. Table 12 presented MDG for the predictor variables associated with the 
HL prediction. 
 Variables Mean 
Decrease Gini 
            
charlsonIndex     
outpatientVS      
careManage        
copdRxpdc         
cardiovascularRx  
Rxcount           
otherChronicRx    
smoker            
gender            
antidepressantRx  
anxiolyticRx      
antibioticRx      
homecareVS        
age               
ER               
 
 
5.16 
3.47 
3.13 
2.07 
1.80 
1.76 
1.75 
1.49 
1.44 
1.35 
1.18 
1.16 
1.04 
1.03 
1.03 
 
 
Table 12. Mean Decrease Gini of the predictor variables for the HL prediction 
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Figure 25 presented plots the top-ten list of important variables ordering variables 
top-to-bottom from the most to the least important variables. The most important 
variable for hospital prediction was CharlsonIndex that mainly described patient 
health status. Another two influential variables were OutpatientVS (i.e., levels of 
frequency of outpatient visits for patients) and careManage (i.e., care management 
that patients received before hospitalization index). There were additionally three 
variables relevant to medical prescriptions including cardiovascularRx (i.e., 
Prescriptions related to cardiovascular disease as antihypertensive or 
antihyperlipidemic), Rxcount (i.e., number of medical prescriptions), 
otherChronicRx (i.e., Prescriptions related to chronic disease besides 
cardiovascular disease). Smoker and gender were two other important variables 
that regarded to patient demographics in the top-ten list of important variables. The 
predictor variables in the top-ten list were considered to feed into RF models for 
external validation by the testing set. 
 
Figure 25. Plots for the top-ten list of important variables for 
hospitalization prediction 
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Model selection for the hospitalization prediction 
Based on the top-ten list of important variables, 8 RF models were created. Each 
of these 8 RF models was fed by decreasing number of variables by 1 from 10 to 
2 most important variables as the following rule:  
 The Base model was randomly using 2 out of 15 variables for the splitting 
node. Next, the RF model 1 was randomly using 2 out of 10 most important 
variables and the RF model 2 was randomly using 2 out of 9 most important 
variables. The RF model 3 was using 2 out of 8 most important variables. 
 Keep decreasing variables in the top-ten list until the variables were less 
than 2 variables. 
By following that rule, the RF model 9 was randomly fed with only 2 most important 
predictors: 
 RF Base Model: charlsonIndex + outpatientVS + careManage + copdRxpdc + car
-diovascularRx + Rxcount + otherChronicRx + smoker + gender + antidepressant
-Rx + anxiolyticRx + antibioticRx + homecareVS + age + ER 
 RF Model 1: charlsonIndex + outpatientVS + careManage + copdRxpdc + cardiov
--ascularRx + Rxcount + otherChronicRx + smoker + gender + antidepressantRx 
 RF Model 2: charlsonIndex + outpatientVS + careManage + copdRxpdc + cardiov
-ascularRx + Rxcount + otherChronicRx + smoker + gender 
 RF Model 3: charlsonIndex + outpatientVS + careManage + copdRxpdc + cardiov
-ascularRx + Rxcount + otherChronicRx + smoker 
 RF Model 4: charlsonIndex + outpatientVS + careManage + copdRxpdc + cardiov
-ascularRx + Rxcount + otherChronicRx 
 RF Model 5: charlsonIndex + outpatientVS + careManage + copdRxpdc + cardiov
-ascularRx + Rxcount 
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 RF Model 6: charlsonIndex + outpatientVS + careManage + copdRxpdc + cardiov
-ascularRx  
 RF Model 7: charlsonIndex + outpatientVS + careManage + copdRxpdc 
 RF Model 8: charlsonIndex + outpatientVS + careManage 
 RF Model 9: charlsonIndex + outpatientVS  
Each model was trained 10 times with the training set. Then, each trained model 
was externally validated by the testing set. The validation results measured by 
Accuracy, Kappa statistic, Sensitivity, Specificity, and AUC were presented in 
Table 13. 
 Model Accuracy (95% CI*) Kappa Sensitivity Specificity AUC 
RF Base Model 85 % (66, 96) 0.69 75 % 93 % 0.84 
RF Model 1 85 % (66, 95) 0.70 83 % 86 % 0.85 
RF Model 2 89 % (70, 98) 0.77 83 % 93 % 0.88 
RF Model 3 85 % (66, 95) 0.70 83 % 86 % 0.85 
RF Model 4 85 % (66, 95) 0.70 83 % 86 % 0.85 
RF Model 5 89 % (70, 98) 0.77 83 % 93 % 0.88 
RF Model 6 85 % (66, 95) 0.70 83 % 86 % 0.85 
RF Model 7 85 % (66, 95) 0.69 75 % 93 % 0.84 
RF Model 8 81 % (61, 93) 0.62 75 % 86 % 0.80 
RF Model 9 85 % (66, 96) 0.69 75 % 93 % 0.84 
 
Table 13. External validation for hospitalization prediction models 
     *CI: Confident interval 
Table 13 indicated both RF model 2 and RF model 5 were the best performance. 
Both models presented high accuracy (89 %) that meant 89 % predicted outcomes 
were correct and good agreement (Kappa = 0.77) between predicted and true 
values in classification of HL and nonHL. Moreover, both models showed high 
sensitivity (83 %) that meant 83 % of the observed HL were correctly predicted 
and high specificity (0.93), thus majority of nonHL in the dataset were correctly 
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predicted. In addition, both models showed high discrimination ability measured by 
the AUC value (0.88). Since RF model 5 was utilized less predictor variables than 
RF model 2, RF model 5 was chosen as the final model for HL prediction. 
 The final model for HL prediction: charlsonIndex + outpatientVS +careManage 
+ copdRxpdc + cardiovascularRx +Rxcount 
Thus, the final model was included 1000 trees and randomly using 2 out of 6 most 
important variables (i.e., charlsonIndex, outpatientVS, careMange, copdRxpdc, 
cardiovascularRx, and Rxcount). Table 14 presented overall performance of the 
final model in training. Across 10 iterations of training with 10,000 trees, the final 
model showed 21.7 % of OOB errors, 26.5 % of misclassification rates for HL, and 
16.5 % of misclassification rates for nonHL. The results of misclassification rates 
over the training set indicated the final model clearly outperformed the RF Base 
model. 
           iteration 
Error 
1 2 3 4 5 6 7 8 9 10 
OOB (SD*)  21.1 
(1.5) 
23.8 
(1.8) 
21.4 
(2.0) 
20.9 
(1.9) 
20.8 
(1.9) 
22.2 
(2.4) 
19.4 
(1.7) 
22.5 
(2.6) 
22.1 
(1.7) 
22.9 
(2.2) 
Misclassification  
for HL (SD*) 
25.6 
(2.4) 
31.1 
(2.7) 
26.0 
(2.5) 
25.9 
(3.1) 
24.3 
(2.7) 
26.8 
(1.8) 
22.8 
(2.8) 
26.2 
(2.7) 
28.2 
(2.9) 
28.5 
(3.5) 
Misclassification  
for nonHL (SD*) 
16.3 
(2.5) 
15.9 
(1.9) 
16.4 
(2.4) 
15.6 
(1.2) 
17.1 
(1.7) 
17.2 
(3.9) 
15.6 
(1.7) 
18.5 
(2.8) 
15.5 
(1.0) 
16.9 
(2.4) 
              
Table 14. Performance of the final model over the training set 
   *SD: Standardization 
Figure 26 (a) depicted overall performance of the final model over 1000 trees in 
the training session. The black line represented for overall OOB errors while the 
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red and green line represented for misclassification rates for HL and nonHL. Figure 
26 (b) presented a tree sample withdrawn from the random forest. 
(a)The final model performance                     (b)Sample tree 
 
 
 
 
      Figure 26. The final model performance in training (a) and a sample tree (b) 
Figure 26 (a) showed the final model was very unstable from 0 to 400 trees but 
more stable after 400 trees. The final model was lightly oscillated in between 600 
and 800 trees due to changes in misclassification rates for nonHL prediction. 
Misclassification rates of HL prediction showed steadily from approximate 590 
trees to 1000 trees. Figure 26 (b) described how a tree model classified patients 
into the HL or nonHL group. For instance, at the first node copdRxpdc was chosen 
to split into two branches. The right branch consisted all patients who ever had 
COPD Rx while the left branch consisted remaining patients who never had COPD 
Rx. For the right branch, if patients ever had care management and all levels of 
charlsonIndex, they were classified into the HL group. If patients never had care 
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management, they turned to two scenarios depended on outpatient visit. One 
scenario was if patients visited outpatient center over level 1 with charlsonIndex 
over level 1, they were classified into the HL group and with charlsonIndex at level 
1, they were classified in the nonHL group. Another scenario was if patients just 
visited outpatient center less than level 1, they were ended up in the nonHL group. 
The final model for hospitalization prediction generated a variable important list 
(see Figure 27). Compared with the list created by the RF Base model, this list was 
slightly different in positions of variables. The positions of variable cardiovascular 
Rx and Rxcount were switched over. 
 
  Figure 27. The final list of important variables for hospitalization prediction 
To describe better relation between predictor variables and predicted outcomes, 
the relation between six predictor variables of the final model and predicted 
outcomes was visualized by partial independence plots (PDP) in both two-
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dimensional plots (2D-PDP) and three-dimensional plots (3D-PDP). PDP 
described the change in the averaged predicted probability of HL as specific 
predictor variables vary over their marginal distribution. 
 
   Figure 28. Partial dependence plots for average of hospitalization predictions 
Figure 28 presented 2D-PDP for each subset of the predictor variables and the 
averaged probability of HL and 3D-PDP for a combination of two subsets of the 
predictor variables and averaged probability of HL. The more varying of the 
response among levels of the predictor the graph showed, the more effect the 
predictor have on the response. For example, the graph 1 of 2D-PDP in Figure 28 
showed the higher level of charlsonIndex, the most important variable, the higher 
effect on HL prediction and the biggest effect going from the level 1 to 2 rather than 
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from the level 2 to 3. The model predicted an average value of about 0.7 on the 
the probability of hospitalization for patients that had the level 3 of charlsonIndex. 
The graph 2 showed a similar trend for outpatientVS that was the higher level of 
outpatientVs, the bigger effect on HL prediction.  
In Figure 28, the graph 4 of 2D-PDP showed hospitalization has weak partial 
dependence on copdRxpdc and an inconsistent trend of effect from level 0 to 2 
that is the biggest effect at the level 0 but the effect at the level 1 was smaller than 
the effect at the level 2. This suggests that this weak main effect may be masking 
stronger interaction effects with other predictors. The graphs of 3D-PDP in Figure 
28 allowed to indicate the interactions by ploting a combination of two variables in 
relation with the changes of HL prediction. The graph 3 of 3D-PDP showed a clear 
interaction between charlsonIndex and copdRxpdc. The averaged probability of 
hospitalization for copdRxpdc given different levels of charlsonIndex had a 
consistent trend at the level 2 and 3 of charlsonIndex that was the effect going 
down and up from the level 0 to 2 of copdRx, whereas for the level 1 of 
charlsonIndex the trend was changed. The averaged probability of hospitalization 
for copdRxpdc was flatted equally between the level 0 and 1 then slightly downed 
to 2. 
Prediction for probability of Hospitalization 
The final model was used to predict probability of HL for the entire dataset of 108 
patients. The results of predicted probabilities of HL for each patient were 
112 
 
presented in Figure 29. In overall, mean, minimum, and maximum of probability 
for HL for the dataset were 0.468 ± 0.357, 0.007, 0.997 respectively. 
 
 
                 
Figure 29. Distribution of probability of hospitalization  
Based on probability of HL for each patient, a ranking for all patients with risk of 
HL could be created. The purpose of the ranking was to separate patients into 
groups at different levels of risk of HL. If risks of HL between 0 and 50 %, between 
50 % and 80 %, and over 80% were considered as low, medium, and high risk 
respectively, patients in the groups of medium and high risk should be more taken 
care of to avoid hospitalizations than patients in the group with low risk.  
Figure 30 described 108 patients were ranked by risk of HL. Patients over the red 
line belonged to the group with high risk of HL while patients between the red line 
and blue line were in medium risk of HL, below the blue line belonged to the group 
with low risk of HL. Among all 108 patients, 28 patients (25.9 %) had high risk of 
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HL, 25 patients (23.1 %) had medium risk of HL, and 55 patients (51.0 %) had low 
risk of HL. Among 28 patients with high risk of HL, 17 patients (60.7 %) had risk of 
HL over 90 %. 
 
        
      Figure 30. Plots for patient ranking with risk of hospitalization 
5.3. Rehospitalization Prediction 
5.3.1. Descriptive analysis 
Characteristics of 73 patients in the analytic sample for ReHL were summarized in 
Table 15. In the sample, 31 patients (42.5 %) were ever re-hospitalized, 33 patients 
(45.2 %) were female, and 43 patients (58.9 %) were over 50 years of age. There 
were only 10 patients (13.7 %) were ever had COPD-related prescriptions in the 
pre-discharge period. In the post-discharge period, 36 patients (49.3 %) never had 
COPD-related prescriptions, 25 patients (34.2 %) had PDC for COPD drugs less 
than 80 %, and 12 patients (16.4 %) had PDC over 80 %. 65 patients (89.0 %) 
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visited outpatient centers, 25 patients (34.2 %) used homecare service, and 36 
patients (49.3 %) visited emergency room. For the group of patients with ReHL, 
the average of follow-up time after discharge was approximately 340 days. For the 
group of patients without ReHL, the average of follow-up after discharge was 
approximately 742 days.  
Patient Characteristics 
    
  n                                      
  Rehospitalization = True (%)               
  gender = 1 (%)                 
  age = 2 (%)                    
  smoker = 1 (%)                 
  Pre_copdRx = 1 (%)             
  Pre_antibioticRx = 1 (%)       
  Pre_careManage = 1 (%)         
  Pre_cardiovascularRx = 1 (%)   
  Post_anxiolyticRx = 1 (%)      
  Post_antibioticRx = 1 (%)      
  Post_careManage = 1 (%)        
  Post_antidepressantRx = 1 (%)  
  Post_cardiovascularRx = 1 (%)  
  Post_otherChronicRx = 1 (%)     
  Post_Rxcount = 2 (%)           
  homecareVS = 1 (%)              
  outpatientVS = 1 (%)           
  ER = 1 (%)                      
  Pre_Rxcount (%)                          
     0                            
     1                            
     2                            
  length.of.stay (%)                       
     1                            
     2                           
     3                            
  Post_copdRxpdc (%)                      
     0                           
     1                           
     2                            
  charlsonIndex (%)                                
     1                            
     2                            
     3                           
 
 
73 
31 (42.5) 
33 (45.2) 
43 (58.9) 
32 (43.8) 
10 (13.7) 
14 (19.2) 
28 (38.4) 
18 (24.7) 
18 (24.7) 
54 (74.0) 
38 (52.1) 
31 (42.5) 
41 (56.2) 
30 (41.1) 
37 (50.7) 
25 (34.2) 
65 (89.0) 
36 (49.3) 
 
17 (23.3) 
43 (58.9) 
13 (17.8) 
 
21 (28.8) 
37 (50.7) 
15 (20.5) 
 
36 (49.3) 
25 (34.2) 
12 (16.4) 
 
19 (26.0) 
40 (54.8) 
14 (19.2) 
 
Table 15. Patient characteristics for rehospitalization analytic sample 
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The sample was stratified by ReHL as Table 16. Among 31 patients with ReHL, 14 
patients (45.2 %) were female, and 21 patients (67.7 %) were over 50 years of 
age. Among 42 patients without ReHL, 19 patients (45.2 %) were female, 22 
patients (52.4 %) were over 50 years of age. 
Patient characteristics  Rehospitalization non-Rehospitalization P 
  n                                      
  gender = 1 (%)                 
  age = 2 (%)                    
  smoker = 1 (%)                 
  Pre_copdRx = 1 (%)             
  Pre_antibioticRx = 1 (%)       
  Pre_careManage = 1 (%)         
  Pre_cardiovascularRx = 1 (%) 
  Post_antidepressantRx = 1 (%) 
  Post_anxiolyticRx = 1 (%)         
  Post_antibioticRx = 1 (%)      
  Post_careManage = 1 (%)        
  Post_cardiovascularRx = 1 (%)  
  Post_otherChronicRx = 1 (%)     
  Post_Rxcount = 2 (%)           
  homecareVS = 1 (%)              
  outpatientVS = 1 (%)           
  ER = 1 (%)                      
  Pre_Rxcount (%)                         
     0                            
     1                            
     2                            
  length.of.stay (%)                       
     1                            
     2                           
     3                            
  Post_copdRxpdc (%)                      
     0                           
     1                           
     2                            
  charlsonIndex (%)                                
     1                            
     2                            
     3                           
31 
14 (45.2) 
21 (67.7) 
12 (38.7) 
  5 (16.1) 
  6 (19.4) 
18 (58.1) 
  8 (25.8) 
12 (38.7) 
10 (32.3) 
21 (67.7) 
16 (51.6) 
19 (61.3) 
12 (38.7) 
13 (41.9) 
11 (35.5) 
28 (90.3) 
19 (61.3) 
 
 8 (25.8) 
16 (51.6) 
 7 (22.6) 
 
12 (38.7) 
13 (41.9) 
  6 (19.4) 
 
18 (58.1) 
7 (22.6) 
6 (19.4) 
 
12 (38.7) 
  8 (25.8) 
11 (35.5) 
42 
19 (45.2) 
22 (52.4) 
20 (47.6) 
  5 (11.9) 
  8 (19.0) 
10 (23.8) 
10 (23.8) 
19 (45.2) 
8 (19.0) 
33 (78.6) 
22 (52.4) 
22 (52.4) 
18 (42.9) 
24 (57.1) 
14 (33.3) 
37 (88.1) 
17 (40.5) 
 
  9 (21.4) 
27 (64.3) 
  6 (14.3) 
 
  9 (21.4) 
24 (57.1) 
  9 (21.4) 
 
18 (42.9) 
18 (42.9) 
  6 (14.3) 
 
  7 (16.7) 
32 (76.2) 
  3 (  7.1) 
 
1.000 
0.281 
0.603 
0.861 
1.000 
    0.006 
** 
1.000 
0.750 
0.308 
0.440 
1.000 
0.603 
0.980 
0.295 
1.000 
1.000 
0.128 
0.516 
 
 
 
0.259 
 
 
 
0.196 
 
 
 
< 0.001 * 
 
 
 
 
(*) for significant at 0.001; (**) for significant at 0.01 
        
   Table 16. Patient characteristics stratified by rehospitalization 
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 While 12 patients (38.7 %) were smoking in the ReHL group, 22 patients (52.4 %) 
were smoking in the nonReHL group. There were only two variables, 
CharlsonIndex and Pre_careMange, showed significant associations with 
rehospitalization while others did not. 
5.3.2. Random Forest model for the rehospitalization prediction 
Data preparation 
 Data division 
Different rates of the data division were crosschecked by running RF model with 
2000 trees using four random variables (i.e., the default value of RF model for the 
dataset with 21 predictor variables) for splitting nodes over the training set. The 
results of OOB values and misclassification rates for ReHL and nonReHL at 
different rates of the data division were presented in Table 17. The results from 
Table 17 showed the RF model performed the best at the rate of 75 % of the entire 
dataset for the training set. The OOB of 75 % for the training set was 29.9 %, while 
the OOB of 55 % and 65 % for the training set were 54.6% and 43.6% respectively. 
 
Estimate of misclassification rate 
 
55 % of data for 
training 
 
65 % of data 
for training 
 
75% of data 
for training 
 
Out of bag error (SD*) 
 
54.6(3.4) 
 
43.6(3.5) 
 
29.9(3.6) 
 
 
Misclassification for ReHL (SD*) 
 
60.8(5.9) 
 
50.4(5.7) 
 
40.4(4.9) 
 
 
Misclassification or non-ReHL (SD*) 
 
48.9(3.1) 
 
37.5(4.7) 
 
21.6(4.8) 
 *SD: Standardization 
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Table 17. Estimate of misclassification for 2000 trees for rehospitalization    
prediction 
Additionally, the plots in Figure 31 (a) and boxplots in the Figure 31 (b) 
demonstrated the RF model running with 2000 trees over the training set sampling 
from 75 % of the data (i.e., blue color) had lower OOB than the RF models using 
the training sets sampling from 55 % (i.e., red color) or 65 % (i.e., green color) the 
entire data set had.  
(a) 
 
 
 
(b) 
 
    Figure 31. OOB of three different ratios of the data division 
                             OOB1: 55 % of data for training 
                             OOB2: 65 % of data for training 
                              OOB3: 75 % of data for training 
The analytic sample for ReHL prediction was randomly divided into 75 % for the 
training set and 25 % for the testing set. Table 18 showed patient characteristics 
in the training set and the testing set. 
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 Patient characteristics Training set   
    N = 54 
Testing set 
    N = 19         
  Rehospitalization = True (%)      
  outpatientVS = 1 (%)        
  Pre_copdRx = 1 (%)        
  Pre_antibioticRx = 1 (%)    
  Post_antidepressantRx = 1 (%)  
  Post_anxiolyticRx = 1 (%)     
  Pre_ cardiovascularRx = 1 (%)     
  Post_antibioticRx = 1 (%)   
  Post_careManage = 1 (%)          
  age = 2 (%)              
  Post_cardiovascularRx = 1 (%)    
  homecareVS = 1 (%)       
  smoker = 1 (%)           
  Post_otherRx = 1 (%)     
  Post_Rxcount = 2 (%)     
  gender = 1 (%)           
  ER = 1 (%)               
  Pre_Rxcount (%)                    
     0                     
     1                     
     2                      
  Length.of.stay (%)                           
     1                     
     2                     
     3                     
  Post_copdRx (%)                    
     0                     
     1                     
     2                      
  Pre_careManage = 1 (%)           
  charlsonIndex (%)                           
     1                      
     2                     
     3                     
 
24 (44.4) 
49 (90.7) 
  7 (13.0) 
11 (20.4) 
21 (38.9) 
12 (22.2) 
17 (31.5) 
43 (79.6) 
28 (51.9) 
33 (61.1) 
31 (57.4) 
18 (33.3) 
23 (42.6) 
21 (38.9) 
26 (48.1) 
22 (40.7) 
27 (50.0) 
 
11 (20.4) 
34 (63.0) 
  9 (16.7) 
 
16 (29.6) 
28 (51.9) 
10 (18.5) 
 
26 (48.1) 
19 (35.2) 
  9 (16.7) 
21 (38.9) 
 
  9 (16.7) 
32 (59.3) 
13 (24.1) 
    7 (36.8)  
  16 (84.2)  
    3 (15.8)  
    3 (15.8)  
  10 (52.6)  
    6 (31.6)  
    1 (  5.3)  
  11 (57.9)  
  10 (52.6)  
  10 (52.6)  
  10 (52.6)  
    7 (36.8)  
    9 (47.4)  
    9 (47.4)  
  11 (57.9)  
  11 (57.9)  
    9 (47.4)  
   
    6 (31.6)  
    9 (47.4)  
    4 (21.1)  
   
    5 (26.3)  
    9 (47.4)  
    5 (26.3)  
   
  10 (52.6)  
    6 (31.6)  
    3 (15.8)  
    7 (36.8)  
   
  10 (52.6)  
    8 (42.1)  
    1 ( 5.3)  
 
                       
Table 18. The training set and testing set for rehospitalization prediction 
In the training set, 24 patients (44.4 %) were re-hospitalized, 22 patients (40.7 %) 
were female, and 33 patients (61.1 %) were over 50 years of age. In the testing 
set, 7 patients (36.8 %) were re-hospitalized, 11 patients (57.9 %) were female, 
and 10 patients (52.6 %) were over 50 years of age. Because the training set was 
not serious imbalance between ReHL (44.4 %) and nonReHL (55.6 %), it was not 
necessary to balance the categorical levels of predicted outcomes. 
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 Finding optimal trees and a subset of random variables for splitting 
node choices by K-fold cross-validation 
A 3-fold cross-validation was applied to internally validate appropriate number of 
trees (ntree) and number of random variables (mtry) for splitting node that would 
use to run RF models over the training set. Each fold of the cross-validation 
consisted 18 patients. The 3-fold cross-validation was utilized to validate tree sizes 
from 500 to 2000 trees and random variables for splitting nodes from 2 to 21 
variables. The largest value for accuracy of model prediction was used to select 
the optimal model. The results of cross-validation across tree sizes and variables 
for splitting nodes were presented in the Figure 32. Figure 32 showed the final 
values used for the RF model were mtry = 7 and ntree = 1500.  
 
Figure 32. 3-fold cross-validation across ntree and mtry for rehospitalization 
prediction 
                     ntree: number of trees for each RF model 
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                    mtry: random variables for each subset 
Model training with bootstrapping samples 
The RF Base model for ReHL prediction was used 1500 trees and 7 random 
variables for splitting node. 1500 bootstrap samples were created from the training 
set to build up 1500 RF models. After 10 times of iteration, there were 15,000 RF 
models built and trained. Table 19 presented estimate of errors for 1500 trees at 
each iteration. The overall misclassification rates for the RF Base model were 
averaged from 15,000 RF trees of 10 iterations. The OOB errors of the RF Base 
model were approximately 28.8 % and misclassification rates for ReHL and 
nonReHL were 37.8 % and 22.2 % respectively. 
    Iteration 
Error 
1 2 3 4 5 6 7 8 9 10 
OOB (SD*)  29.2 
(2.2) 
26.9 
(2.2) 
28.9 
(2.8) 
28.5 
(2.4) 
26.5 
(3.2) 
31.6 
(4.2) 
27.5  
(4.4) 
30.3 
(3.7) 
29.9 
(3.6) 
28.6 
(2.9) 
Misclassification  
for ReHL (SD*) 
39.3 
(3.4) 
35.1 
(3.1) 
39.3 
(2.9) 
36.5 
(3.4) 
37.1 
(3.1) 
39.6 
(7.2) 
36.1 
(5.4) 
40.1 
(5.3) 
39.2 
(6.9) 
35.2 
(3.6) 
Misclassification  
for nonReHL (SD*) 
20.4 
(2.2) 
22.5 
(5.4) 
20.2 
(3.2) 
22.2 
(3.8) 
19.4 
(3.3) 
22.3 
(3.3) 
23.5 
(2.5) 
23.6 
(5.3) 
23.6 
(3.6) 
23.8 
(4.1) 
 
Table 19. The RF Base model performance on training for 
rehospitalization prediction 
                        *SD: Standard deviation 
Variable importance for rehospitalization prediction 
Important predictor variables for the RF Base models were listed in Table 20. Table 
20 presented an order of all 21 predictor variables by MDG.  
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Variables Mean Decrease Gini 
                  
charlsonIndex  
Post_copdRx  
Pre_careManage  
Length.of.stay 
gender  
Pre_Rxcount  
Post_cardiovascularRx               
ER 
smoker  
Post_antibioticRx  
homecareVS  
Post_otherChronicRx      
Post_anxiolyticRx               
age  
Post_careManage  
Post_Rxcount      
Pre_cardiovascularRx  
Post_antidepressantRx  
Pre_antibioticRx        
Pre_copdRx         
outpatientVS  
 
 
5.85 
2.19 
2.10 
1.82 
1.23 
1.19 
1.13 
1.13 
0.96 
0.95 
0.90 
0.87 
0.85 
0.81 
0.78 
0.77 
0.75 
0.65 
0.45 
0.32 
0.27 
 
Table 20. Mean Decrease Gini of predictor variables for 
rehospitalization prediction 
Figure 33 presented a plot ranking for top-ten variables from low to high MDG. All 
predictor variables in the top-ten list were considered to feed into RF models then 
externally validated by the testing set. Like HL prediction, the most important 
variables for ReHL prediction was charlsonIndex that mainly described patient 
health status. For the pre-discharge period, two influential variables were 
Pre_careManage (i.e., care management) and Pre_Rxcount (i.e., counts of 
number of medical prescriptions). For the post-discharge period, there were 
variables relevant to medical prescriptions including Post_copdRx (i.e., proportion 
of COPD drugs covered), Post-cardiovascularRx (i.e., Prescriptions related to 
drugs to treat cardiovascular disease as antihypertensive or antihyperlipidemic), 
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and Post_antibioticRx (i.e., Prescriptions for antibiotics). Besides, length.of.stay 
(i.e., duration time spending in hospital), gender, ER visit, smoker was four other 
important variables that influenced to predicted outcomes. 
 
Figure 33. Plots for the top-ten list of important variables for 
rehospitalization prediction 
Model selection for rehospitalization prediction 
From the top-ten list of important variables, four RF models were created. Each of 
these models was fed by decreasing number of variables by one from 10 to 7 most 
important variables. For instance, while the RF Base model was used all 21 
variables, the RF model 1 was built with 10 most important variables and the RF 
model 2 was created with nine most important predictors.  By doing so, the RF 
model 4 was fed with seven most important variables. 
 RF Base Model: charlsonIndex + Post_copdRx + Pre_careManage + Length.of.st
ay + gender + Pre_Rxcount + Post_cardiovascularRx + ER + smoker + Post_anti
bioticRx + homecareVS + Post_otherChronicRx + Post_anxiolyticRx + age + Pos
t_careManage + Post_Rxcount +   Pre_cardiovascularRx + Post_antidepressantR
x + Pre_antibioticRx +  Pre_copdRx + outpatientVS  
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 RF Model 1: charlsonIndex + Post_copdRx + Pre_careManage + Length.of.stay +  
            gender + Pre_Rxcount + Post_cardiovascularRx + ER + smoker +  
            Post_antibiotic  Rx 
 RF Model 2: charlsonIndex + Post_copdRx + Pre_careManage + Length.of.stay +  
            gender + Pre_Rxcount + Post_cardiovascularRx + ER + smoker 
 RF Model 3: charlsonIndex + Post_copdRx + Pre_careManage + Length.of.stay +  
            gender + Pre_Rxcount + Post_cardiovascularRx + ER 
 RF Model 4: charlsonIndex + Post_copdRx + Pre_careManage + Length.of.stay +  
            gender + Pre_Rxcount + Post_cardiovascularRx  
Each model was trained 10 times with the training set. Then, each trained model 
was externally validated by the test set. The validation results measured by 
Accuracy, Kappa statistic, Sensitivity, Specificity, and AUC were shown as Table 
21. 
 
 
              Table 21. External validation for rehospitalization prediction models 
Both the RF model 2 and 3 had the same values for all measures and outperformed 
others. Both models showed high accuracy (89 %) that was 89 % correct prediction 
for ReHL and nonReHL over all predictions, good agreement (Kappa = 0.79) 
between predicted and true values in classification of ReHL and nonReHL. In 
addition, both showed high sensitivity (100.0 %) that meant 100 % of all patients 
 Model Accuracy (95 % CI) Kappa Sensitivity Specificity AUC 
RF Base Model 84 % (60, 96) 0.69 100.0 % 75 % 0.88 
RF Model 1 84 % (60, 96) 0.69 100.0 %      75 % 0.88 
RF Model 2 89 % (60, 99) 0.79     100.0 % 83 % 0.92 
RF Model 3 89 % (60, 99) 0.79  100.0 % 83 % 0.92 
RF Model 4 79 % (54, 94) 0.54   71.0 % 83 % 0.77 
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being re-hospitalized who were correctly identified by the models and high 
specificity (83 %) that was 83 % of all patients not being re-hospitalized who were 
correctly identified by the models. Since the final model was the model utilized less 
variables, the RF model 3 was selected as the final model for ReHL prediction. 
 The final model for ReHL prediction: charlsonIndex + Post_copdRx + Pre_care
Manage + Length.of.stay + gender + Pre_Rxcount + Post_cardiovascularRx  + E
R  
The final model for ReHL prediction was included 1500 trees and using 7 random 
variables of out 8 most important variables (i.e., charlsonIndex, Post_copdRx, 
Pre_careManage, length.of.stay, gender, Pre_Rxcount, Post_cardiovascularRx, 
and ER) for splitting node choices. Table 22 showed overall performance of the 
final model for ReHL prediction and a sample tree from the random forest. Across 
10 iterations in training generating 15,000 trees, the final model showed 24.6 % of 
OOB errors, 34.1 % of misclassification rates for HL, and 17.0 % of 
misclassification rates for nonHL.  
          Iteration 
Error 
1 2 3 4 5 6 7 8 9 10 
OOB (SD*)  24.4 
(1.2) 
24.2 
(2.6) 
24.3 
(1.3) 
25.2 
(1.8) 
25.1 
(2.0) 
23.7 
(2.4) 
24.2 
(2.3) 
25.4 
(1.4) 
24.8 
(2.0) 
24.8 
(1.5) 
Misclassification  
for ReHL (SD*) 
34.2 
(2.2) 
32.1 
(2.6) 
33.3 
(2.4) 
36.0 
(2.8) 
35.3 
(3.7) 
31.9 
(3.3) 
33.1 
(2.8) 
36.1 
(2.2) 
35.2 
(3.6) 
33.4 
(0.9) 
Misclassification  
for nonReHL 
(SD*) 
16.5 
(1.7) 
17.9 
(3.5) 
17.1 
(1.6) 
16.5 
(1.6) 
16.9 
(2.4) 
17.2 
(2.2) 
16.9 
(2.1) 
16.8 
(1.5) 
16.5 
(1.1) 
17.8 
(2.5) 
   
   Table 22. Final model performance for rehospitalization prediction in training 
          *SD: Standard deviation  
Figure 34 (a) visually showed OOB (i.e., black line), misclassification rates for 
ReHL and nonReHL (i.e., red and green line). It indicated that the final model 
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performed stably after 500 trees. The sample tree in Figure 34 (b) described how 
the final model performed to classify ReHL and nonReHL for patients in the training 
set. For instance, at the first node charlsonIndex was chosen to split into two 
branches. The right branch consisted all patients who had charlsonIndex with level 
two while the left branch consisted remaining patients who had charlsonIndex with 
level 1 or 3. For the right branch, if patients were male, had PDC for COPD-related 
drugs less than 80%, and did not have cardiovascular-related prescriptions during 
post-discharge, they would be in the nonReHL group. If the patients had 
cardiovascular-related prescriptions during post-discharge, they would be in the 
ReHL group. If the patients had no COPD-related prescriptions or PDC for COPD-
related drugs over 80%, they would end up in the ReHL group. Another situation 
was if patients were female and length of stay in hospital at level 2, they would be 
in the nonReHL group. If they stayed in hospital at level 1 or 3, charlsonIndex at 
level 1, and no COPD-related prescriptions, they would be in the nonReHL group. 
If they had COPD-related prescriptions, they would be in the ReHL group. 
 
a. Performance of the final model  
 
 
       b. Sample tree  
 
 
 
 
Figure 34. The final model performance and a tree sample for 
rehospitalization prediction 
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ReHL: Rehospitalization; nReHL: Non-Rehospitalization; Cci: 
charlsonIndex; Pre_CM: Pre_careManage; los: length.of.stay  
The final model created a new list of important variables (see Figure 35). 
Compared with the list created by the RF Base model, four variables in the top 
were not changed in possitions. Changing possitions occured for four variables 
down the list, including Post_cardivascularRx, Pre_Rxcount, gender, and ER.  
 
Figure 35. The final list of important variables for 
rehospitalization prediction 
Figure 36 presented 2D PDPs for the probability of ReHL varying as each subset 
of a specific predictor changes with others fixed and 3D PDPs for a combination 
of each two subsets of the predictors changes and varying of the probability of 
ReHL. For example, the graph 2 of 2D PDPs showed the effect of Post_copdRx 
on probabilities of ReHL. Because the variances of the effect of each level were 
large, Post_copdRx had high effect on ReHL prediction. The level 0 of 
Post_copdRx had more effect on ReHL than both the level 1 and the level 2. The 
graph 1 of 3D PDPs  described further details about a combination of 
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charlsonIndex and Post-copdRx in relation with the changes of ReHL prediction. 
The 3D PDP showed an interaction between charlsonIndex and Post_copdRx. In 
level 3 of charlsonIndex, the graph showed  changes of ReHL prediction depended 
on Post_copdRx. The level 3 of charlsonIndex had highest effect on ReHL 
prediction at the lowest level of Post_copdRx. While charlsonIndex had a clear 
intereaction with almost fed predictors in the model, it showed an unclear 
interaction with gender. 
 
   Figure 36. Partial dependence plots for average of rehospitalization predictions 
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cci: charlsonIndex; Pst_cpR: Post_copdRx; Pre_CM: Pre_careManage; 
los: length.of.stay; Pr_Rxcn: Pre_Rxcount; Pst_crR: 
Post_cardiovascularRx 
Prediction for rehospitalization 
The final RF model was used to predict the probability of ReHL for the entire 
dataset of 71 patients. The results of predicted probabilities of ReHL for each 
patient were presented in Figure 36. In overall, mean, minimum, and maximum of 
probability for ReHL for the entire analytic sample were 0.45 ± 0.35, 0.007, 0.997 
respectively. 
 
       Figure 37. Distribution of probability of rehospitalization 
Based on the probability of ReHL for each patient, a ranking of all patient with risk 
of ReHL could be created. Figure 38 showed plots for probability of ReHL for 71 
patients ordering top-to-bottom from high risk of ReHL (over 80 %) to low risk of 
ReHL (less than 50 %). Patients with probability falling between 50 % and 80 % 
were considered as medium risk of ReHL.  
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Figure 38. Plots for patient rankings with risk of rehospitalization 
Among all 71 patients, 21 patients (29.5 %) had high risk of ReHL, 12 patients 
(16.9 %) had medium risk of ReHL, and 38 patients (53.6 %) had low risk of HL. 
Among 21 patients with high risk of ReHL, 9 patients (42.8 %) had risk of ReHL 
over 90 %. 
5.4. Summary 
The final analytic samples for HL and ReHL prediction consisted 108 patients and 
71 patients respectively. By applying the RF technique, two predictive models for 
HL and ReHL were created. The RF model for HL prediction was built with 1000 
trees and randomly picked up 2 out of 6 most important variables. Six variables 
mainly contributed to HL prediction were charlsonIndex, outpatientVS, 
careManage, copdRxpdc, cardiovascularRx, and Rxcount.  For ReHL prediction, 
the RF model was included 1500 trees and randomly used 7 out of 8 most 
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influential variables. Eight variables mainly contributed to ReHL prediction were 
charlsonIndex, Post_copdRx, Pre_careManage, length.of.stay, gender, 
Pre_Rxcount, Post_cardiovascularRx, and ER. The RF model for HL prediction 
was combined 10,000 trees to predict probability of HL for each patient among 108 
patients of the analytic sample for HL prediction while the RF model for ReHL 
prediction was combined 15,000 trees to predict probability of ReHL for each 
patient among 71 patients of the analytic sample for ReHL prediction. Based on 
probability of HL or ReHL predicted by the RF models, the ranking for risk of HL or 
ReHL were feasible to be generated and applied in practice for COPD treatment 
and patient management. 
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Chapter 6. DISCUSSION 
To reduce avoidable hospitalizations, the Centers for Medicare & Medicaid 
Services (CMS) established the Hospital Readmissions Reduction Program 
(HRRP) to reduce potential avoidable hospitalizations for some chronic diseases. 
In 2012, the program began imposing penalties for excessive rehospitalizations. 
These penalties have driven healthcare systems to find and implement evidence-
based interventions to decrease hospitalizations. Understanding factors that 
contributes to these avoidable hospitalizations become very important in the effort 
to develop evidence-based interventions aims at their reduction.   
In October 2014, COPD was included as a part of the HRRP. Most hospitalization 
and rehospitalizations among COPD patients come from exacerbations marked by 
worsening respiratory symptoms, including difficulty breathing and excess phlegm 
production. Symptom burden from exacerbations may last long from days to 
months, depending on disease severity, the patient’s functional status before the 
exacerbation, and comorbid conditions. Factors associated with a higher risk of 
hospitalization or rehospitalization in literature included a variety of causes such 
as demographic factors (i.e., male sex or black race (vs. white)), health status (i.e., 
comorbid conditions), lower socioeconomic status, and worse health on 
discharge... 
There were two aims for this study. The first aim was to specify and examine 
important factors for predicting all-cause hospitalization for patients with COPD. 
The second aim was to verify and examine important predictors that predict the 
first all-cause rehospitalization of a patient with COPD. These two aims were 
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investigated in two samples derived from a cohort of patients with COPD. To 
address these aims, this study applied the RF technique to: 
1. Build a reliable RF model for identifying the contributing predictors: 
 Models were built from multiple random bootstrapping samples and random 
subsets of predictors 
 Models were internally validated by misclassification errors and the 3-fold 
cross-validation 
2. Validate the models for model selection: the underlying concept is to 
examine if model is a good classification model that indicates the 
combination of the predictors fed into the model is truly contributing to the 
predicted outcomes. 
 Models were externally validated by a new test set 
3. Test predictive ability of the final model with a whole data set: 
 A good model performance on the whole data set indicates information from 
the data set is adequate to predict the outcomes and the contributing 
predictors are necessary for the models 
 Expanding the meaning of the model findings to apply for practice by 
ranking patients at different levels of risks to hospitalization and 
rehospitalization 
The two aims were underlying the concepts of Chronic Care Model that considers 
healthcare as an interprofessional care model in which nursing, social work, 
respiratory therapy, primary care and specialist clinicians, and others 
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collaboratively develop care strategies. Thus, patient outcome depends on more 
than one factor extracted out from characteristics of patient and practice team, or 
community and hospital. In this study, RF models were fit in accordance with the 
outcomes as a binary variable (HL=True and nonHL= False / ReHL = True and 
nonReHL = False). 
In this chapter, the first section summarizes and discusses the study findings. The 
second section discusses the strengths of this study. The third section presents 
limitations of this study. The fourth section discusses the implications of the study. 
Finally, the fifth section provides recommendations for future research. 
6.1. Summary of the study results 
By applying a nested case-control design, the analytic sample for hospitalization 
prediction consisted of 108 patients with COPD. Fifty-four cases were matched 
with fifty-four controls by age and gender. For the analytic sample for 
rehospitalization prediction, the study applied prospective cohort design to create 
a sample including 73 patients with COPD.  
First, one advantage of RF is to apply OOB error as an internal validation that 
reflects both accuracy of classification and adaptability of the model data. By using 
default values for the two most important parameters in RF, this study found that 
a ratio of 75:25 was the best partitioning ratio for the whole dataset, for the training 
set, and the test set. To improve validity for the study, the 3-fold cross-validation 
was applied to find optimal values for the model parameters (i.e., number of tree 
sizes and number of random subset of variable used to split each tree node). The 
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results from the 3-fold cross-validation indicated that the optimal model for 
hospitalization prediction should consist 1000 RF trees and use a random 
subgroup of two variables for splitting nodes. For the rehospitalization prediction, 
the optimal model should include 1500 RF trees and use a random subgroup of 
seven variables for splitting nodes. To improve reliability for the study, RF models 
for hospitalization and rehospitalization were repeated 10 times to generate 10,000 
RF tree models for hospitalization prediction and 15,000 RF tree models for 
rehospitalization prediction from several random samples. The values of OOB 
errors and MDG were averaged over the RF trees for model evaluation. 
Second, this study applied the Gini Impurity Index measure identified for the RF 
approach to classify variable importance. The Gini Impurity Index measure was 
mathematically proved by the Theory of Information Gain. The underlying concept 
of the Gini Impurity Index measure is that every time a split of a node is made on 
a variable, the Gini Impurity criterion for the two descendent nodes is less than the 
parent node. Thus, adding up the Gini decreases for each variable over multiple 
forests demonstrates variable importance. By using Mean Decrease Gini (MDG), 
RF models of this study generated the top-ten lists of predictor variable importance 
for hospitalization and rehospitalization prediction (see Figures 25 & 33 in chapter 
5) 
Third, RF models built by the variables in the top-ten lists then were validated by 
the test set. The validation procedure with the test set allowed selection from the 
best models for hospitalization and rehospitalization prediction.  
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 HL prediction: charlsonIndex + outpatientVS + careManage + copdRxpdc + 
cardiovascularRx + Rxcount 
 ReHL prediction: charlsonIndex + Post_copdRx + Pre_careManage + 
Length.of.stay + gender + Pre_Rxcount + Post_cardiovascularRx + ER 
The final lists of important variables contributing final models for hospitalization 
prediction and rehospitalization prediction (see Figures 27 and 35 of Chapter 5) 
differed slightly from the top-ten lists created by the RF base models.  
6.1.1. Important predictors for hospitalization model 
For hospitalization prediction, charlsonIndex (i.e., comorbid condition scores) was 
categorized into 3 levels of comorbid conditions that included patients with only 
COPD in level 1, patients with a combination of COPD and another chronic disease 
in level 2, and patients with COPD and more than one chronic diseases in level 3. 
The Levels of comorbid conditions were significantly associated with 
hospitalization (p < 0.001) (see Table 8 in Chapter 5) and it seems that patients 
with hospitalization tend to have higher levels of comorbidities. When the 
comorbid-related variable was fed into the RF model with others, the MDG 
measurement denoted it was the most important variable in identifying the subset 
of patients at the risk of hospitalization. This finding is consistent with the result 
from a cross-sectional study of Miravitlles et al., (2000). Miravitlles et al., (2000) 
demonstrated the existence of coexisting comorbidities was related with an 
increased risk of admission (Miravitlles et al., 2000). Typically, an explanation for 
the association between comorbid conditions and the risk of hospitalization is that 
comorbidity appears to be a risk factor for severe life-threatening exacerbations 
that possibly provoked hospitalization. In addition, this study found a trend showing 
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high level of the comorbid scores contributed to high effect on the risk of 
hospitalization (see Figure 28 of the chapter 5). Since all co-morbidities for COPD 
patients are important contributing factors to hospitalization, a special attention 
should be paid to the diagnosis of coexisting disease for the group of patients with 
COPD to come up with appropriate and timely interventions or care strategies to 
avoid the risk of hospitalization.  
Outpatient visits have not been fully investigated as important predictors of 
hospitalization in patients with COPD in many previous studies for hospitalization 
prediction. In this study, there was an evidence that outpatient visit was the second 
important predictors related to the increased risk of hospitalization. The outpatient-
visit-related-variable categorized into 3 levels regrading frequencies of outpatient 
visits that consisted patients never visiting outpatient center during the study period 
in level 0, patients visiting from 1 to 3 times in level 1, and patients visiting more 
than 3 times in level 2. Outpatient visits were significantly associated with 
hospitalization (P = 0.001) (see Table 8 in Chapter 5) and patients with 
hospitalization seem to have higher numbers of outpatient visits. In addition, this 
study found the higher outpatient patients visited, the higher effect on risk of HL 
patients got (see Figure 28 of the chapter 5). Andersson et al. (2002) defined a 
moderate exacerbation leading hospitalization as requiring a visit to an outpatient 
facility (Andersson, Borg, & Jansson, 2002).The association of outpatient visits 
with the risk of hospitalization in patients with COPD may be due to worsening of 
COPD exacerbation or health status that leads patients to hospitalization. While 
our study indicated that high number of outpatient visits seemed to be a sign for 
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increasing the risk of hospitalization, a study of health insurance claims over the 
period 1999 through 2002 found that the number of hospital admissions decreased 
while the number of outpatient visits increased over this period (Nurmagambetov 
et al., 2006). In practice, although exacerbations of COPD could be managed in 
the outpatient setting, patients with acute exacerbation of COPD could cause 
respiratory failure with severe hypoxia or respiratory acidosis that required 
hospitalization to an intensive care unit for management (Celli et al., 2004). 
Therefore, it is uncertain that increasing number of outpatient visits will reduce 
hospitalizations. The difference of the outpatient visit-related finding between this 
study and Nurmagambetov et al., (2006) can be due to the different data sets used 
for extracting information to feed into the models for each study. 
Care management is the third important predictor of the important list for the 
hospitalization prediction in this study. Care management was included risk factors 
as lack of vaccination, oxygen therapy use, or spirometry test. This finding 
supports for previous studies that stated the use of oxygen therapy as the risk 
factor of hospitalization. For instance, Kessler et al., (1999) reported that Long 
Term use of Oxygen Therapy (LTOT) significantly increased the risk of 
hospitalization for acute exacerbations of COPD (Kessler et al., 1999). Garcia-
Aymerich et al., (2001) stated that LTOT was a risk factor for hospitalization in a 
case-control study (Garcia-aymerich et al., 2001). While the use of spirometry test 
was researched as a component of the COPD severity that was a risk factor of HL 
(Yu, Zhou, Suh, & Arcona, 2015), it has not been fully inspected as a single factor. 
Regarding to vaccination status, Nichol et al., (1999) found influenza vaccination 
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was a risk factor associated with fewer hospitalizations and a reduced mortality in 
a retrospective study for elderly patients with COPD (Nichol, Baken, & Nelson, 
1999). In GOLD guideline for the management of COPD, influenza vaccination is 
recommended for all patients with mild, moderate, or severe COPD. Garcia-
Aymerich et al., (2001), however, pointed out that lack of influenza vaccination 
could act as a marker of severity because of its association with a high risk of 
hospitalization in the crude analysis, but it did not indicate any relation in the 
adjusted model. From this study’s findings, it is required to have further studies 
that need to focus on examining the role of spirometry test and vaccination as a 
single factor contributing to the hospitalization prediction for patients with COPD.  
The PDC for COPD drugs (i.e., specific COPD drugs, respiratory, and 
corticosteroid) was found as the fourth important predictor of hospitalization. The 
results from this study supported the previous studies that found that adherence 
of COPD drugs could be a risk factor for the hospitalization prediction. For 
instance, Wei et al., (2014) performed a randomized controlled study to examine 
effect of pharmaceutical care on non-adherence patients with COPD. They found 
pharmaceutical care improved adherence of medication for COPD treatment that 
considerably reduced hospitalizations (Wei et al., 2014). For details of group of 
drugs for COPD intervention, although literature demonstrated that inhaled 
corticosteroid was independently associated with hospitalization (Bourbeau, Ernst, 
Cockcoft, & Suissa, 2003), the effect of respiratory or specific COPD drugs (e.g., 
short or long acting bronchodilator and theophylline) were not fully investigated. 
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The findings from this study pointed out that these groups of drugs for COPD 
treatment could be potential risk factors for the HL prediction. 
For other variables related to health utilization as number of prescription and 
cardiovascular prescription status, although the descriptive analyses of this study 
indicated that there was no significant association with hospitalization, the final RF 
model for the hospitalization prediction implied they were important variables in 
predicting the risk of hospitalization. While the association between COPD and 
heart disease was clear, heart disease among COPD patient contributing to 
hospitalization was unclear in literature. In practice, it is clear evidence that COPD 
and heart disease influence each other. For example, fluid in patient lungs from 
heart disease makes breathing harder if patients with COPD. Reasonably, COPD 
patients are more vulnerable to heart attack or strokes than others, thus an 
exacerbation, a serious eruption in symptoms, can lead COPD patient to 
hospitalization. The finding of this study showed that cardiovascular prescription 
seemed to be higher effect on the hospitalization prediction than non-
cardiovascular prescription (see Figure 28 of Chapter 5). It suggests 
cardiovascular prescription of patient with COPD can be a marker of potential 
exacerbation that causes hospitalization.  For demographic-related variables as 
gender and age, while female and age was reported as predictive factors for 
reduced hospitalization after adjustment for the self-management intervention in a 
multicenter, randomized controlled trial (Gadoury et al., 2005), our study supported 
a statement of Garcia-Aymerich et al., (2001) that neither age nor gender were 
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found to be a related to hospitalization for COPD patients (Garcia-aymerich et al., 
2001). 
6.1.2. Important predictors for rehospitalization model 
In practice of intervention for COPD, there may be a possible interruption of 
intervention for COPD patients when the patient’s care across various setting. With 
COPD patients with multiple coexisting comorbid conditions, the specialist could 
not communicate effectively with the patient and caregivers. There is the need for 
care models in both the pre-discharge and post-discharge periods that increase 
the likelihood of safe transitions from hospital to home. This study generated the 
risk factors for the rehospitalization prediction regarding to two periods of 
intervention programs. The final RF model for the rehospitalization prediction 
implied four most important variables were respectively charlsonIndex, 
Post_copdRx, PrecareManage, length.of.stay. 
The variable, charlsonIndex, denoted comorbid conditions for patients with COPD 
was the first most important variable for the rehospitalization prediction. In addition, 
comorbid conditions were associated with rehospitalization (p < 0.001) (see Table 
16 in Chapter 5) and patients with rehospitalization seem to have higher comorbid 
conditions.  The findings provided support for the result from a retrospective study 
of Lau et al., (2001). Lau et. al., (2001) found comorbidities such as right heart 
strain on electrocardiogram, diabetes mellitus, coronary artery disease, stable 
chronic left ventricular failure were significant risk factors for early rehospitalization 
on univariate analysis (Lau et al., 2001). Lau et al., (2001) believed that the 
comorbidities except for asthma, bronchiectasis, and restrictive lung diseases 
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were important factors contributing to COPD morbidity (Lau et al., 2001). 
Moreover, this study pointed out the Charlson comorbid scores over three 
contributed to high effect on the prediction of rehospitalization (see Figure 36 of 
the chapter 5). Like the role of comorbidities for hospitalization prediction, all 
comorbidities for COPD patients are very important contributing factors to predict 
the risk of rehospitalization, thus, the diagnosis of coexisting diseases for patients 
with COPD and the intervention plans for all these comorbidities need to be 
considered as important as the diagnosis and interventions for COPD.  
Several studies showed corticosteroid and other COPD medications were 
significantly associated with rehospitalization (Aaron et al., 2007); (Hiscock & Wu, 
2017). Because of the use of multiple medications, patients with COPD usually 
end up with medical adherence problem that is a high-risk factor leading 
rehospitalization. For example, In addition to concurrent therapy for other 
comorbidities (e.g., diabetes, hypertension, and coronary heart disease), 
aerosolized medications from two to six times daily are often prescribed for 
patients with COPD that obviously makes them difficult to keep track their 
treatment. In this study, the variable related to the adherence of COPD 
medications post discharge (i.e., Post_copdRx) was found as the second important 
predictor of rehospitalization. This finding supported a statement of Laswell et al., 
(2015) which stated that patients with COPD who received discharge medication 
counseling to improve medication adherence had lower readmission rates post 
discharge (Laswell, Svelund, Harzler, & Chen, 2015). In addition, this study 
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indicated that non-prescription of COPD medication (i.e., Post_copdRx = 0) had 
high effect on the rehospitalization prediction (see Figure 36 of Chapter 5). 
Two next important variables are Pre_careManage and length.of.stay. Both factors 
obtained during pre-discharge were related to rehospitalization. For variable 
related to the length of hospital stay, length.of.stay, this study found the lengths of 
stay over 5 days seemed to be more effect on rehospitalization prediction (see 
Figure 36 of Chapter 5). This finding supports the result from a study of Lau et al., 
(2001) that indicated that the lengths of stay over 5 days were significantly 
associated with rehospitalization (Lau et al., 2001). The variable, 
Pre_careManage, described diagnosis of lack of vaccination, oxygen therapy use, 
or spirometry test that happened at the time of patient’s hospitalization. While 
literature review indicated that some of these factors was associated with 
rehospitalization, it has not been researched whether these factors at the time of 
admission may influence rehospitalization prediction. For instance, Menon et al., 
(2008) following up patients with COPD one-year before and after influenza 
vaccination concluded that influenza vaccination was associated with fewer 
rehospitalizations. However, the study made conclusion based on all patients 
recruited before a hospitalization. Considering importance of vaccination in the 
management of COPD, further researches on vaccination should be opened 
broader to other vaccination as pneumococcal vaccination (at least one) for 
patients with COPD. One more variable in pre-discharge found to be importance 
was cardiovascular prescription status. For post discharge, there are two variables 
considered to be contributing factors in the model of rehospitalization prediction 
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were number of prescriptions and emergency visit status. For patient demographic 
characteristics, gender was found to be important for the rehospitalization 
prediction. 
6.1.3. Individual patient ranking for hospitalization and rehospitalization 
In addition to the list of variable importance, the final models were applied to the 
whole data set to report a ranking for individual patients with different risk levels of 
hospitalization and rehospitalization. In the analytic sample for the hospitalization 
prediction, the final model found 51.0 % at low risk level (P Hospitalization < 50), 23.1 
% at the medium risk level (50 % ≤ P Hospitalization < 80 %), and 25.9 % of patients at 
high risk level (i.e., P Hospitalization ≥ 80%). In the analytic sample for the 
rehospitalization prediction, the final model found 53.6 % at low risk level (P 
Rehospitalization < 50), 16.9 % at the medium risk level (50 % ≤ P Rehospitalization < 80 %), 
and 29.5 % of patients at high risk level (P Rehospitalization ≥ 80 %). These findings 
from this study expand to a suggestion for a research area on risk prediction 
modeling based on real-time characteristics of patients and healthcare systems to 
keep track risk of patients with COPD for hospitalization and rehospitalization. 
6.2. Strength of the study 
There are several strengths in this study. First, the study applied a robust 
technique, Random Forest, for predictive modeling for hospitalization and 
rehospitalization. The application of random forests is a robust approach to identify 
important variables using a process that runs over cross-validated results, direct 
tests of predictive accuracy to create reliable results by aggregating results of 
multiple models. The RF allows avoiding the limitation of scarce data by generating 
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several random samples from the bootstrap method. In addition, by applying the 
RF approach, it also provides protection from over-fitting the data by the properties 
of the RF (i.e., randomness of samples for the model building and variable 
subgroup for splitting nodes) which can produce unreliable results. These 
properties are to make sure that the results of random forest analysis are true 
representations of the relations between the important variables and targeted 
outcomes in the study sample. 
Second, we assert that the partition of dataset influences on adaptive ability of RF 
models, missing a validation for the partition makes the results of RF analysis from 
several existing studies less convincing. Given the established robustness of OOB 
assessment in the RF method, we examined the partition of dataset that would 
give the lowest values of OOB errors to find out the optimal cut-point for dividing 
the whole dataset into the training set and the testing set. Since the OOB errors 
were aggregated from multiple RF tree models generated from several random 
samples, the reliability of study is established. 
Third, the RF in this study is conducted in both internal and external validation that 
provide more robust evidence of validity than existing studies. Two important 
parameters in RF are random subsets of variables for splitting tree nodes and 
random tree sizes optimized. Regularly, studies in literature which used default 
values of the random subsets of variables (i.e., square root of number of variables) 
to find tree sizes or accepted tree sizes available from the previous studies. This 
study, however, applied an internal validation used the 3-fold cross-validation 
taken both parameters at the same time into account for the evaluation of model 
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accuracy. The internal validation is to assure that the models use optimal values 
for both parameters to maximize the predictive accuracy. Next, the model with 
optimal values of parameters was externally validated by the test set which 
contained observations that were completely different from ones in the training set. 
By combining internal external validation, this study demonstrated that the 
superiority of our model in comparison with current models regarding to various 
criteria. Further, although the RF models avoids overfitting by its properties, 
combining internal validation and external validation allowed confirming that the 
high discrimination ability of this study model was irrespective to overfitting. 
Fourth, our aims are to address the problem of classifying patients for potentially 
preventable hospitalizations. Using administrative data for our algorithm is 
appropriate and accurate to extract out information related to risk factors of 
hospitalization or rehospitalization compared to existing studies that used clinical 
data. For instance, outpatient visits in the prehospitalization period or post 
discharge are important in assessing hospitalization and rehospitalization. 
Lastly, giving a specific list of important variables for rehospitalization prediction 
related to both pre-discharge and post discharge. It is a great support for the 
disease management and intervention for patients with COPD to prevent 
rehospitalization. To limit bias for the nature of the RF method usually ignored by 
some previous studies using RF (i.e., favoring categorical variables when a mix of 
continuous variable and categorical existing, or favoring variables with more 
classes if substantial difference existing among categorical variables), this study 
used variables at categorical form and make sure that there are no substantial 
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different classes among them to limit the bias in important ranking of variables. In 
addition, this study also examined imbalance issue of data set that can cause 
inaccurate prediction for the outcome because RF may favor the class with more 
observations. 
6.3. Limitation of this study 
Even though our results introduced new aspects that contribute to statistical 
technique, study design, and measurements of risk factors and outcomes for 
hospitalization and rehospitalization, there are some limitations related to 
generalizability, data source, and variable measurement. 
First, the data used in the study is from a group of self-insured employer group in 
Midwest, with a population that is mostly employees and their dependences; 
hence, the results may not be generalized for other populations. For instance, 
since we found small size of final cohort for patients with COPD in the population 
of our study, a possible reason could be this population is healthier than another 
in the previous studies. Our study, however, applied RF which use the bootstrap 
method to generate several random samples for model building, thus the limitation 
for the size of population did not affected on the accuracy of findings. 
Second, the study is limited to administrative data, thus our data does not have 
clinical information as laboratory test results that may influence on model 
performance due to possibly missing some predictors that may highly contribute 
to the predicted outcome. Because in practice, physicians are recommended to 
combine clinical information and other factors to make decision for whether patient 
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needs to admit to hospital or not. In addition, literature has identified limitations 
using claims data source. For instance, diagnosis-coding errors could exist and 
result in either an underestimation or an overestimation of the diagnosis of patients 
with COPD. Assignment of ICD-9 and CPT codes are dependent on 
documentation in medical records that may or may not be adequately detailed to 
assign appropriate codes. It is also important to note that claims data originates 
for adjudicating health insurance claims and are used only secondarily for health 
economics and outcomes research. Thus, the limitation of using claims data for 
measuring health outcomes is true of any study that utilizes claims data for other 
purposes rather than adjudicating health insurance claims. This may affect the 
definition of variable. For example, although CMS defines a hospitalization as a 
24-hour period or two more midnights in the hospital, claims data do not often 
include a time-stamp that indicates both the date and time of admission and 
discharge. Therefore, for this study a hospitalization can only be defined by using 
date.  
Third, this study did not have mortality data and socioeconomic data. Thus, 
patients who died within hospitalization or post-discharge were not excluded that 
could influence the accuracy of prediction. Recently, socioeconomic factors should 
be considered in the model for hospitalization as CMS recommendation (National 
Quality Forum, 2017b), but our data sets do not have information related to 
socioeconomic. 
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6.4. Implication of the findings of this study 
This study was driven to identify risk factors for hospitalization and 
rehospitalization, expectedly eliminating potentially avoidable hospitalizations for 
patient with COPD as a desirable goal by practitioners and policy makers. 
Traditionally, intervention is usually designed to focus on patients with only one 
disease to cure or prevent the development of disease; there are so-called 
population of patient with COPD, with heart disease, or with diabetes or so on in 
clinical practice. This study, however, reveals that a complete package of multiple 
interventions and programs may be necessary to treat for patients with many 
health problems now. The finding that the factor related to comorbid conditions for 
patients with COPD was the most important risk factors for both prehospitalization 
and post discharge is consistent with evidence from literature and concern of 
practitioners in practice. From a view of the management of COPD, this finding 
implies that preventing deterioration of comorbid conditions, through coordinated, 
continuous, optimal care management of all health concerns, is necessary to 
improve the health of patients with COPD. The need for continuous care is 
confirmed by the importance of the presence of comorbid conditions for both the 
hospitalization and rehospitalization models.  
Continuity of care for COPD using the WHO guidelines suggests that there be 
appropriate assessment of the underlying COPD condition, identification and 
management of contributory risk factors such as smoking, and stabilizing and 
managing COPD. From the hospitalization and rehospitalization models, the 
following care management recommendations can be made: 
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Before hospitalization, a disease management program for COPD covering the 
assessment, risk factor control, and COPD management should be developed with 
considering the community engagement. The variable related to care management 
is on the list of important variables for the hospitalization model in this study. 
Besides lack of vaccination and oxygen therapy use, presence of spirometry is one 
of elements contributing to the variable. Global Initiative for Obstructive Lung 
Disease (GOLD) recommended to use spirometry for the diagnosis of COPD and 
assessment of disease severity (GOLD, 2006). Although the finding of this study 
has not fully confirmed that spirometry test is important for the hospitalization 
model, as combining with the recommendation of GOLD about spirometry, this 
factor should be paid attention from practitioners. Bolton et al., (2005) found that 
many primary care practitioners mainly focused on clinical information alone for 
the diagnosis of COPD and assessment of disease severity (Bolton et al., 2005). 
Several reasons accounts for this situation including poor recognition of important 
role of spirometry or lack of adequate training in use and interpretation. Thus, there 
is necessary for further education on awareness of the role and use of spirometry 
targeted primary care practitioners. In the period of prehospitalization, besides the 
self-management of patients with the diagnosis of COPD, the role of outpatient 
care center is important. This study found outpatient visit could be a vital predictor 
for hospitalization model. In managing COPD, outpatient clinics should be served 
as a great source that help to manage COPD in community to prevent patients 
from hospitalization. For example, outpatient clinics can lead COPD management 
programs (e.g., patient education on knowledge of COPD or COPD medication) to 
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incur patients with COPD to improve their ability of self-management. Nurses and 
physiotherapist at outpatient clinics can regularly organize patient education 
sessions for groups or individuals depending on COPD levels of severity to deliver 
COPD awareness and precaution for exacerbations highly associated with 
hospitalization for patients with COPD. In COPD, improving patient adherence to 
medication is essential that also is what this study found. This study found the 
variable related to adherence of COPD drugs is one of risk predictors of 
hospitalization. To manage the adherence to COPD medication, it should not only 
be several specific educations for patients but follow-up discussions on adherence 
to regiments at each patient visit. Finally, although history of smoking is not found 
importance for hospitalization model, it should not be a risk factor that patients and 
practitioners can ignore. A possible explanation is that history of smoking has been 
always underestimated in many studies due to errors related to data source.  
For the rehospitalization model, pre-discharge care planning should be as 
important as post-discharge care follow-up to prevent risk of rehospitalization for 
patients with COPD because the earlier risk factors are detected, the better the 
prevention of rehospitalization is. Jennings et al., (2015) conducted a clinical trial 
to examine if a pre-discharge bundle allowed to reduce rehospitalization rates 
(Jennings et al., 2015). They found the pre-discharge bundle significantly reduced 
rehospitalization rates. In pre-discharge planning, the assessment of COPD 
patients is very important to classify patients for the levels of COPD exacerbations. 
Like the hospitalization model, the rehospitalization model of this study identified 
the variable related to presence of spirometry, vaccination, and oxygen therapy 
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use is important predictor. If the assessment of patients in the prehospitalization 
period should be focused on the accurate diagnosis of COPD to ensure not to be 
both under-diagnosed and over-diagnosed for COPD, the assessment in pre-
discharge should be focused on classifying patients into each stage of COPD. 
Spirometry is needed to support for clinical information to decide whether patients 
should be in mild, moderate, severe, or very severe COPD. In pre-discharge 
planning, this study found length of stay is a risk factor contributing to 
rehospitalization. Since literature indicated the length of stay over 5 days was 
significantly associated with rehospitalization (Lau et al., 2001), COPD patients 
with the length of stay over 5 should be paid special attention. The length of stay 
should be considered to account for classifying patients as a guideline of COPD 
management. In post-discharge care follow-up, adherence to COPD medication is 
important in the rehospitalization model of this study. This finding is making a lot 
of sense since the nature complication of such a chronic disease as COPD. 
Patients with COPD are always under stressed to adhere to their medications, 
because they are required to take multiple medications for a long-term care. Thus, 
the follow-up care (e.g., phone call or mail for reminding) for patients with COPD 
is very important to prevent risk of further rehospitalization. The follow-up time post 
discharge, however, is not standardized yet that suggests a need for further 
research. Besides adherence to COPD drugs, this study showed the presence of 
cardiovascular prescription is important for the rehospitalization model in post 
discharge. This suggests that among many comorbid conditions patients with 
COPD have to face with, healthcare practitioners should be paid close attention to 
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cardiovascular disease. In pathological pathway, COPD increases risk of 
cardiovascular disease and then cardiovascular disease can worsen COPD 
exacerbations that lead patients to rehospitalizations. The relation between COPD 
and cardiovascular disease also suggests an add-on for the guideline of COPD 
management in post-discharge care follow-up that a cardiovascular management 
program including both assessment and management is necessary for patients 
with COPD as well. 
6.5. Recommendation for further research 
We would like to recommend some work for future research in methods and 
disease management. For the methods, this study applied the machine learning 
technique, Random Forest, for classification outcomes (i.e., hospitalization and 
rehospitalization). First, as we discussed in Chapter 4, this study created 
categorical variables to avoid bias in ranking variable importance related to the 
RF’s properties favoring variable with multiple classes. While we believe that our 
decision on categorizing variables based on carefully considering suggestions 
from literature is appropriate, we recommend that further research on predictive 
modeling for hospitalization and rehospitalization will examine the risk factors in 
this study under continuous form. It will help to evaluate the risk factors whether 
they are stably contributing to hospitalization and rehospitalization under 
continuous form.  Second, from findings of this study and literature reviews, we 
realize that the variable related to comorbid conditions has been demonstrated as 
the most important factor for both hospitalization and rehospitalization model. 
Because its important role, further research on this variable is necessary. This 
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study and many other studies in literature applied the Deyo-Charlson Index to 
measure for comorbid condition scores. Thus, we recommend the further research 
using different comorbidity indices to examine if the comorbidity-related variable 
still maintains as the most important risk factor. Third, regarding to the 
measurement of variable, we suggest measuring separately for each of these 
factors in care management (i.e., spirometry, vaccination, and oxygen therapy) to 
confirm fully their effect on the predicted outcomes. Fourth, like other machine 
learning approaches, RF is criticized as a “black box” because it is difficult to 
explain a causal relationship due to the complex of RF (i.e., including many models 
inside). Thus, we recommend using a combination of RF with other methods (e.g., 
regression models) to expand findings for the research questions of this study.  
For disease management, although there are many programs and interventions to 
deal with increasing hospitalization rates for COPD patients, it seems lack of 
standardization and agreement between one and another. For instance, although 
GOLD recommended to use spirometry for patient assessment, a study found 
physicians from many countries used only clinical information to make decision on 
the assessment (Bolton et al., 2005). We suggest that the COPD management 
program needs a consistent plan besides going further details for each plan. For 
example, a COPD national action plan, recently released in August, 2017 by 
National Heart, Lung, and Blood Institute (NHLBI), is a promising advancement in 
the COPD management (NHLBI, 2017). This program is expected to provide a 
comprehensive framework for both patients who are affected by the COPD burden 
and healthcare providers who are working to reduce the burden.   
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Variable ICD-9-CM codes 
careManage For oxygen therapy: 
E0424-E0444 for oxygen therapy 
 E0445 for oximeter device 
 E1390-E1392 for oxygen concentrator 
 E1405-E1406 for oxygen and water vapor enriching systems 
 93.96 for oxygen therapy 
For spirometry: 
94010 for spirometry including graphic record 
94014 for patient initiated spirometry 
94015 for patient initiated spirometry 
94016 for physician review/interpretation of spirometry 
94060 for bronchospasm evaluation w/ spirometry (pre vs post 
bronchodilator 
For lack of vaccination: 
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V 15.83 for personal history of under immunization 
V 04.81 for need of Influenza vaccination 
V 06.6 for need of pneumonia and influenza vaccination 
charlsonIndex 
(Quan et al., 2005) 
410, 412 for myocardial infarction = 1;   
428 for congestive heart failure = 1;     
441, 443.9, 785.4, V43.4 for peripheral vascular disease = 1;      
430, 431, 432, 433, 434, 435, 436, 437, 438 for 
cerebrovascular disease = 1; 
290 for dementia = 1; 
490, 491, 492, 494, 496 for COPD=1;      
710.0, 710.1, 710.4, 714.0, 714.1, 714.2, 725, 714.81 for 
rheumatologic disease = 1;      
531, 532, 533, 534 for peptic ulcer disease = 1;    
571.2, 571.5, 571.6, 571.4 for mild liver disease = 1;     
342, 344.1 for hemiplegia = 2;  
250.01, 250.02, 250.03, 250.07 for diabetes without 
complication = 1;    
250.04, 250.05, 250.06 for diabetes with complication = 2;     
582, 583, 585, 586, 588 for renal disease = 2;    
140-172, 174-195, 200-208 for non-metastatic cancer = 2; 
572.2-572.8,456.0-456.21 for moderate or severe liver disease 
= 3; 
196, 197, 198, 199.0,199.1 for metastatic cancer = 6;   
 042, 043,044 for aids = 6;   
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